SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Advanced Container Technologies, Inc. – ‘10-Q’ for 6/30/22 – ‘XML’

On:  Monday, 8/22/22, at 3:29pm ET   ·   For:  6/30/22   ·   Accession #:  1683168-22-5991   ·   File #:  0-29381

Previous ‘10-Q’:  ‘10-Q’ on 5/20/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/14/22 for 9/30/22   ·   Latest:  ‘10-Q/A’ on 11/15/22 for 9/30/22

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/22/22  Advanced Container Techs, Inc.    10-Q        6/30/22   53:3.7M                                   GlobalOne Filings Inc/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    752K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     16K 
11: R1          Cover                                               HTML     63K 
12: R2          Consolidated Balance Sheets (Unaudited)             HTML    106K 
13: R3          Consolidated Balance Sheets (Unaudited)             HTML     37K 
                (Parenthetical)                                                  
14: R4          Consolidated Statements of Operations (Unaudited)   HTML     77K 
15: R5          Consolidated Statements of Operations (Unaudited)   HTML     34K 
                (Parenthetical)                                                  
16: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     91K 
17: R7          Consolidated Statement of Stockholder's Equity      HTML     55K 
                (Deficit) (Unaudited)                                            
18: R8          Description of Business and Organization            HTML     22K 
19: R9          Summary of Significant Accounting Policies          HTML    115K 
20: R10         Going Concern                                       HTML     20K 
21: R11         Intangible Assets and Goodwill                      HTML     68K 
22: R12         Convertible Notes Payable and Promissory Notes      HTML     56K 
                Payable                                                          
23: R13         Stockholders? Equity                                HTML     28K 
24: R14         Share-Based Compensation                            HTML     35K 
25: R15         Income Taxes                                        HTML     23K 
26: R16         Related-Party Transactions                          HTML     27K 
27: R17         Concentrations                                      HTML     30K 
28: R18         Commitments                                         HTML     20K 
29: R19         Subsequent Events                                   HTML     19K 
30: R20         Summary of Significant Accounting Policies          HTML    156K 
                (Policies)                                                       
31: R21         Summary of Significant Accounting Policies          HTML     78K 
                (Tables)                                                         
32: R22         Intangible Assets and Goodwill (Tables)             HTML     66K 
33: R23         Convertible Notes Payable and Promissory Notes      HTML     51K 
                Payable (Tables)                                                 
34: R24         Share-Based Compensation (Tables)                   HTML     29K 
35: R25         Related-Party Transactions (Tables)                 HTML     22K 
36: R26         Summary of Significant Accounting Policies          HTML     64K 
                (Details) - Disaggregation of revenue                            
37: R27         Summary of Significant Accounting Policies          HTML     22K 
                (Details) - Schedule of customer deposits payable                
                balance and the significant activity affecting                   
                customer deposits                                                
38: R28         Summary of Significant Accounting Policies          HTML     47K 
                (Details Narrative)                                              
39: R29         Going Concern (Details Narrative)                   HTML     21K 
40: R30         Intangible Assets and Goodwill (Details) -          HTML     59K 
                Schedule of intangible assets and goodwill                       
41: R31         Convertible Notes Payable and Promissory Notes      HTML     78K 
                Payable (Details)                                                
42: R32         Stockholders? Equity (Details Narrative)            HTML     29K 
43: R33         Share-Based Compensation (Details) - Schedule of    HTML     24K 
                share based compensation                                         
44: R34         Share-Based Compensation (Details Narrative)        HTML     33K 
45: R35         Income Taxes (Details Narrative)                    HTML     21K 
46: R36         Related-Party Transactions (Details) - Schedule of  HTML     22K 
                related party transactions                                       
47: R37         Related-Party Transactions (Details Narrative)      HTML     24K 
48: R38         Concentrations (Details Narrative)                  HTML     34K 
51: XML         IDEA XML File -- Filing Summary                      XML     91K 
49: XML         XBRL Instance -- advanced_i10q-063022_htm            XML   1.08M 
50: EXCEL       IDEA Workbook of Financial Reports                  XLSX     86K 
 7: EX-101.CAL  XBRL Calculations -- actx-20220630_cal               XML    114K 
 8: EX-101.DEF  XBRL Definitions -- actx-20220630_def                XML    261K 
 9: EX-101.LAB  XBRL Labels -- actx-20220630_lab                     XML    568K 
10: EX-101.PRE  XBRL Presentations -- actx-20220630_pre              XML    450K 
 6: EX-101.SCH  XBRL Schema -- actx-20220630                         XSD     95K 
52: JSON        XBRL Instance as JSON Data -- MetaLinks              252±   361K 
53: ZIP         XBRL Zipped Folder -- 0001683168-22-005991-xbrl      Zip    165K

‘XML’   —   XBRL Instance — advanced_i10q-063022_htm

This Document is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:actx="http://advancedcontainertechnologies.com/20220630" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<link:schemaRef xlink:href="actx-20220630.xsd" xlink:type="simple"/>
<context id="From2022-01-01to2022-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-08-22">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<instant> 2022-08-22 </instant>
</period>
</context>
<context id="AsOf2022-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:ConvertiblePreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:ConvertiblePreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2022-04-012022-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="AsOf2020-12-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="From2022-01-012022-03-31_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_custom_SeriesAPreferredStocksMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> actx:SeriesAPreferredStocksMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_FurnitureAndFixturesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:FurnitureAndFixturesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_srt_MinimumMember_us-gaap_ComputerEquipmentMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:ComputerEquipmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_srt_MaximumMember_us-gaap_ComputerEquipmentMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:ComputerEquipmentMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_LeaseholdsAndLeaseholdImprovementsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis"> us-gaap:LeaseholdsAndLeaseholdImprovementsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_srt_MinimumMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_srt_MaximumMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_GrowPodsAndRelatedItemsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:GrowPodsAndRelatedItemsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_GrowPodsAndRelatedItemsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:GrowPodsAndRelatedItemsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_GrowPodsAndRelatedItemsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:GrowPodsAndRelatedItemsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_GrowPodsAndRelatedItemsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:GrowPodsAndRelatedItemsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_MedtainersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:MedtainersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_MedtainersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:MedtainersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_MedtainersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:MedtainersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_MedtainersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:MedtainersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_LightersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:LightersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_LightersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:LightersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_LightersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:LightersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_LightersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:LightersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_HumidityPackInsertsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:HumidityPackInsertsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_HumidityPackInsertsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:HumidityPackInsertsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_HumidityPackInsertsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:HumidityPackInsertsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_HumidityPackInsertsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:HumidityPackInsertsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_PlasticLighterHoldersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PlasticLighterHoldersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PlasticLighterHoldersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PlasticLighterHoldersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_PlasticLighterHoldersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PlasticLighterHoldersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PlasticLighterHoldersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PlasticLighterHoldersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_PrintingMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PrintingMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PrintingMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PrintingMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_PrintingMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PrintingMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PrintingMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PrintingMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_ShippingChargesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:ShippingChargesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ShippingChargesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:ShippingChargesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_ShippingChargesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:ShippingChargesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ShippingChargesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:ShippingChargesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_JarsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:JarsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_JarsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:JarsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_JarsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:JarsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_JarsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:JarsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_OthersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:OthersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OthersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:OthersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_OthersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:OthersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OthersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:OthersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AllProductsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:AllProductsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AllProductsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:AllProductsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_LightersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:LightersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_LightersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:LightersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_LightersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:LightersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_LightersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:LightersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_MedtainersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:MedtainersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_MedtainersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:MedtainersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_MedtainersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:MedtainersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_MedtainersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:MedtainersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_GrowPodsAndRelatedItemsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:GrowPodsAndRelatedItemsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_GrowPodsAndRelatedItemsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:GrowPodsAndRelatedItemsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_GrowPodsAndRelatedItemsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:GrowPodsAndRelatedItemsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_GrowPodsAndRelatedItemsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:GrowPodsAndRelatedItemsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_HumidityPackInsertsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:HumidityPackInsertsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_HumidityPackInsertsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:HumidityPackInsertsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_HumidityPackInsertsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:HumidityPackInsertsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_HumidityPackInsertsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:HumidityPackInsertsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_PlasticLighterHoldersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PlasticLighterHoldersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PlasticLighterHoldersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PlasticLighterHoldersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_PlasticLighterHoldersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PlasticLighterHoldersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PlasticLighterHoldersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PlasticLighterHoldersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_PrintingMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PrintingMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PrintingMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PrintingMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_PrintingMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PrintingMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PrintingMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:PrintingMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_OthersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:OthersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OthersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:OthersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_OthersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:OthersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OthersMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:OthersMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_ShippingChargesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:ShippingChargesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ShippingChargesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:ShippingChargesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_ShippingChargesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:ShippingChargesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ShippingChargesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:ShippingChargesMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_JarsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:JarsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_JarsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:JarsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_JarsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:JarsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_JarsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:JarsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AllProductsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:AllProductsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AllProductsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis"> actx:AllProductsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_DistributorshipAgreementMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:DistributorshipAgreementMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_DistributorshipAgreementMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:DistributorshipAgreementMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_USPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:USPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_USPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:USPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_USPatents2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:USPatents2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_USPatents2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:USPatents2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_CanadianPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:CanadianPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_CanadianPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:CanadianPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_EuropeanPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:EuropeanPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_EuropeanPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:EuropeanPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_MoldsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:MoldsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_MoldsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:MoldsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_TrademarkMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> actx:TrademarkMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_TrademarkMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> actx:TrademarkMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_DomainNameMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> actx:DomainNameMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_DomainNameMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> actx:DomainNameMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_DistributorshipAgreementMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:DistributorshipAgreementMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_DistributorshipAgreementMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:DistributorshipAgreementMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_USPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:USPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_USPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:USPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_USPatents2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:USPatents2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_USPatents2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:USPatents2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_CanadianPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:CanadianPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_CanadianPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:CanadianPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_EuropeanPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:EuropeanPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_EuropeanPatentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:EuropeanPatentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_MoldsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:MoldsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_MoldsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis"> actx:MoldsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_TrademarkMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> actx:TrademarkMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_TrademarkMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> actx:TrademarkMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_DomainNameMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> actx:DomainNameMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_DomainNameMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis"> actx:DomainNameMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_ConvertibleNotesPayable1Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:ConvertibleNotesPayable1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_ConvertibleNotesPayable1Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:ConvertibleNotesPayable1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_ConvertibleNotesPayable2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:ConvertibleNotesPayable2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_ConvertibleNotesPayable2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:ConvertibleNotesPayable2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_ConvertibleNotesPayableMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_ConvertibleNotesPayableMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> us-gaap:ConvertibleNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_NotesPayable1Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_NotesPayable1Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_NotesPayable2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_NotesPayable2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_NotesPayable3Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable3Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_NotesPayable3Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable3Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_TotalNotesPayableMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:TotalNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_TotalNotesPayableMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:TotalNotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_ConvertibleNotesPayable1Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:ConvertibleNotesPayable1Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="AsOf2018-02-22_custom_ConvertibleNotesPayable2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:ConvertibleNotesPayable2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2018-02-22 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_ConvertibleNotesPayablesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:ConvertibleNotesPayablesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_ConvertibleNotesPayablesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:ConvertibleNotesPayablesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2015-08-15_custom_NotesPayable2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2015-08-15 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_NotesPayable2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_NotesPayable2Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable2Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_NotesPayableMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_NotesPayableMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayableMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_NotesPayable3Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable3Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_NotesPayable3Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> actx:NotesPayable3Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-01-02_srt_DirectorMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> srt:DirectorMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-01-02 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_FourUnrelatedPersonsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:FourUnrelatedPersonsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-12-31_custom_EightUnrelatedPersonsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:EightUnrelatedPersonsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="AsOf2018-12-31_custom_Plan2018Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis"> actx:Plan2018Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2018-12-31 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_Plan2018Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> actx:Plan2018Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_Plan2018Member">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> actx:Plan2018Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2018-12-012018-12-31_custom_EmployeesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:EmployeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2018-12-31 </endDate>
</period>
</context>
<context id="From2018-12-012018-12-31_custom_ConsultantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:ConsultantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2018-12-31 </endDate>
</period>
</context>
<context id="From2018-12-012019-01-02_custom_EmployeesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:EmployeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2019-01-02 </endDate>
</period>
</context>
<context id="From2018-12-012019-01-02_custom_ConsultantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:ConsultantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2019-01-02 </endDate>
</period>
</context>
<context id="From2018-12-012019-03-31_custom_EmployeesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:EmployeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2019-03-31 </endDate>
</period>
</context>
<context id="From2018-12-012019-03-31_custom_ConsultantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:ConsultantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2019-03-31 </endDate>
</period>
</context>
<context id="From2018-12-012019-06-30_custom_EmployeesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:EmployeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2019-06-30 </endDate>
</period>
</context>
<context id="From2018-12-012019-06-30_custom_ConsultantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:ConsultantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2019-06-30 </endDate>
</period>
</context>
<context id="From2018-12-012020-06-30_custom_EmployeesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:EmployeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2020-06-30 </endDate>
</period>
</context>
<context id="From2018-12-012020-06-30_custom_ConsultantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:ConsultantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2020-06-30 </endDate>
</period>
</context>
<context id="From2018-12-012022-06-30_custom_EmployeesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:EmployeesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2018-12-012022-06-30_custom_ConsultantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis"> actx:ConsultantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2018-12-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2021-12-31_custom_FederalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis"> actx:FederalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_StateMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis"> actx:StateMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_LoansMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseAxis"> us-gaap:LoansMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_LoansMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseAxis"> us-gaap:LoansMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_BuildingLeasePaymentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> actx:BuildingLeasePaymentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_BuildingLeasePaymentsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> actx:BuildingLeasePaymentsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_PurchaseOfProductsForResaleMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> actx:PurchaseOfProductsForResaleMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_PurchaseOfProductsForResaleMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis"> actx:PurchaseOfProductsForResaleMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:AnotherCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:AnotherCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:AnotherCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:AnotherCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:SalesRevenueNetMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_CostOfGoodsMember_us-gaap_ProductConcentrationRiskMember_custom_OneDistributorMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneDistributorMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> actx:CostOfGoodsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:ProductConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_CostOfGoodsMember_us-gaap_ProductConcentrationRiskMember_custom_OneDistributorMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneDistributorMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> actx:CostOfGoodsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:ProductConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_CostOfGoodsMember_us-gaap_ProductConcentrationRiskMember_custom_OneDistributorMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneDistributorMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> actx:CostOfGoodsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:ProductConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_CostOfGoodsMember_us-gaap_ProductConcentrationRiskMember_custom_OneDistributorMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneDistributorMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> actx:CostOfGoodsMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:ProductConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:AnotherCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:OneCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001096950 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:MajorCustomersAxis"> actx:AnotherCustomerMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis"> us-gaap:AccountsReceivableMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis"> us-gaap:CustomerConcentrationRiskMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-12-31 </endDate>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<unit id="Pure">
<measure> pure </measure>
</unit>
<dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-06-30"> 0001096950 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="From2022-01-01to2022-06-30"> false </dei:AmendmentFlag>
<dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-06-30"> --12-31 </dei:CurrentFiscalYearEndDate>
<dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-06-30"> 2022 </dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-06-30"> Q2 </dei:DocumentFiscalPeriodFocus>
<us-gaap:CommitmentsAndContingencies contextRef="AsOf2022-06-30" id="xdx2ixbrl0113" unitRef="USD" xsi:nil="true"/>
<us-gaap:CommitmentsAndContingencies contextRef="AsOf2021-12-31" id="xdx2ixbrl0114" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-03-31_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0376" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0379" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0384" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0385" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0386" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0400" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0401" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0402" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-01-012021-03-31_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0426" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0429" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-01-012021-03-31_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0434" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0437" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0442" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0443" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0444" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0458" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0459" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0460" unitRef="USD" xsi:nil="true"/>
<dei:DocumentType contextRef="From2022-01-01to2022-06-30"> 10-Q </dei:DocumentType>
<dei:DocumentQuarterlyReport contextRef="From2022-01-01to2022-06-30"> true </dei:DocumentQuarterlyReport>
<dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-06-30"> 2022-06-30 </dei:DocumentPeriodEndDate>
<dei:DocumentTransitionReport contextRef="From2022-01-01to2022-06-30"> false </dei:DocumentTransitionReport>
<dei:EntityFileNumber contextRef="From2022-01-01to2022-06-30"> 000-29381 </dei:EntityFileNumber>
<dei:EntityRegistrantName contextRef="From2022-01-01to2022-06-30"> ADVANCED CONTAINER TECHNOLOGIES, INC. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-06-30"> FL </dei:EntityIncorporationStateCountryCode>
<dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-06-30"> 65-0207200 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-06-30"> 1620 Commerce St. </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-06-30"> Corona </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-06-30"> CA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-06-30"> 92878 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="From2022-01-01to2022-06-30"> (951) </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="From2022-01-01to2022-06-30"> 381-2555 </dei:LocalPhoneNumber>
<dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-06-30"> Yes </dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-06-30"> Yes </dei:EntityInteractiveDataCurrent>
<dei:EntityFilerCategory contextRef="From2022-01-01to2022-06-30"> Non-accelerated Filer </dei:EntityFilerCategory>
<dei:EntitySmallBusiness contextRef="From2022-01-01to2022-06-30"> true </dei:EntitySmallBusiness>
<dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-06-30"> false </dei:EntityEmergingGrowthCompany>
<dei:EntityShellCompany contextRef="From2022-01-01to2022-06-30"> false </dei:EntityShellCompany>
<dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-08-22" decimals="INF" unitRef="Shares"> 51901525 </dei:EntityCommonStockSharesOutstanding>
<us-gaap:Cash contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 101155 </us-gaap:Cash>
<us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 59367 </us-gaap:Cash>
<us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 221341 </us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 229941 </us-gaap:AccountsReceivableNetCurrent>
<us-gaap:InventoryNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 432705 </us-gaap:InventoryNet>
<us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 438333 </us-gaap:InventoryNet>
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 18345 </us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 17663 </us-gaap:PrepaidExpenseCurrent>
<actx:PrepaidInventory contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 333000 </actx:PrepaidInventory>
<actx:PrepaidInventory contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 279625 </actx:PrepaidInventory>
<us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1106546 </us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1024929 </us-gaap:AssetsCurrent>
<us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 170966 </us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
<us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 162018 </us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 38773 </us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 47721 </us-gaap:PropertyPlantAndEquipmentNet>
<actx:IntangibleAssetsNetOfAccumulatedAmortization contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 639274 </actx:IntangibleAssetsNetOfAccumulatedAmortization>
<actx:IntangibleAssetsNetOfAccumulatedAmortization contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 508870 </actx:IntangibleAssetsNetOfAccumulatedAmortization>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1792726 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1923130 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1020314 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1020314 </us-gaap:Goodwill>
<us-gaap:DepositsAssets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 8699 </us-gaap:DepositsAssets>
<us-gaap:DepositsAssets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 8699 </us-gaap:DepositsAssets>
<us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 3967058 </us-gaap:Assets>
<us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 4024793 </us-gaap:Assets>
<us-gaap:AccountsPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 494069 </us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 458495 </us-gaap:AccountsPayableCurrent>
<us-gaap:InterestPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 90609 </us-gaap:InterestPayableCurrent>
<us-gaap:InterestPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 88461 </us-gaap:InterestPayableCurrent>
<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 602986 </us-gaap:EmployeeRelatedLiabilitiesCurrent>
<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 501395 </us-gaap:EmployeeRelatedLiabilitiesCurrent>
<actx:CustomerDepositsPayable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 487336 </actx:CustomerDepositsPayable>
<actx:CustomerDepositsPayable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 361230 </actx:CustomerDepositsPayable>
<us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 81172 </us-gaap:ConvertibleNotesPayableCurrent>
<us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 81172 </us-gaap:ConvertibleNotesPayableCurrent>
<us-gaap:OtherNotesPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 129249 </us-gaap:OtherNotesPayableCurrent>
<us-gaap:OtherNotesPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 287487 </us-gaap:OtherNotesPayableCurrent>
<us-gaap:DueToOfficersOrStockholdersCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 386896 </us-gaap:DueToOfficersOrStockholdersCurrent>
<us-gaap:DueToOfficersOrStockholdersCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 320411 </us-gaap:DueToOfficersOrStockholdersCurrent>
<us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 2272317 </us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2098651 </us-gaap:LiabilitiesCurrent>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.00001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.00001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="Shares"> 10000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="Shares"> 10000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 10 </us-gaap:PreferredStockValue>
<us-gaap:PreferredStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 10 </us-gaap:PreferredStockValue>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares"> 0.00001 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares"> 0.00001 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares"> 100000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 100000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares"> 51901525 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares"> 51901525 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 51621524 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 51621524 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 519 </us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 516 </us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 8495063 </us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 8285066 </us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> -6800851 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -6359450 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1694741 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1926142 </us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 3967058 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 4024793 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 739342 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 758572 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 1665490 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 2631530 </us-gaap:Revenues>
<us-gaap:CostOfGoodsAndServicesSold contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 532131 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 491828 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 1140100 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:CostOfGoodsAndServicesSold contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 2041869 </us-gaap:CostOfGoodsAndServicesSold>
<us-gaap:GrossProfit contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 207211 </us-gaap:GrossProfit>
<us-gaap:GrossProfit contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 266744 </us-gaap:GrossProfit>
<us-gaap:GrossProfit contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 525390 </us-gaap:GrossProfit>
<us-gaap:GrossProfit contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 589661 </us-gaap:GrossProfit>
<us-gaap:MarketingAndAdvertisingExpense contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 29522 </us-gaap:MarketingAndAdvertisingExpense>
<us-gaap:MarketingAndAdvertisingExpense contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 17604 </us-gaap:MarketingAndAdvertisingExpense>
<us-gaap:MarketingAndAdvertisingExpense contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 77991 </us-gaap:MarketingAndAdvertisingExpense>
<us-gaap:MarketingAndAdvertisingExpense contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 32431 </us-gaap:MarketingAndAdvertisingExpense>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 5750 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 5750 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:DepreciationAndAmortization contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 69516 </us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 69384 </us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 138539 </us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 139824 </us-gaap:DepreciationAndAmortization>
<us-gaap:ProfessionalFees contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 50576 </us-gaap:ProfessionalFees>
<us-gaap:ProfessionalFees contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 51048 </us-gaap:ProfessionalFees>
<us-gaap:ProfessionalFees contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 152899 </us-gaap:ProfessionalFees>
<us-gaap:ProfessionalFees contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 128121 </us-gaap:ProfessionalFees>
<us-gaap:ShareBasedCompensation contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 270000 </us-gaap:ShareBasedCompensation>
<us-gaap:LaborAndRelatedExpense contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 225752 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 349244 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 409304 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 464062 </us-gaap:LaborAndRelatedExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 88873 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 69090 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 172170 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 136818 </us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:OperatingExpenses contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 469989 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 556370 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 956653 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 1171256 </us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -262778 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -289626 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -431263 </us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -581595 </us-gaap:OperatingIncomeLoss>
<us-gaap:InterestExpense contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 5506 </us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 7786 </us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 10138 </us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 12790 </us-gaap:InterestExpense>
<us-gaap:NonoperatingGainsLosses contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -5506 </us-gaap:NonoperatingGainsLosses>
<us-gaap:NonoperatingGainsLosses contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -7786 </us-gaap:NonoperatingGainsLosses>
<us-gaap:NonoperatingGainsLosses contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -10138 </us-gaap:NonoperatingGainsLosses>
<us-gaap:NonoperatingGainsLosses contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -12790 </us-gaap:NonoperatingGainsLosses>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -268284 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -297412 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -441401 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -594385 </us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasic contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareBasic contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareBasic contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareBasic contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="Shares"> 51901525 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="Shares"> 51901525 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="Shares"> 51621524 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="Shares"> 51621524 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="Shares"> 51867971 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="Shares"> 51867971 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="Shares"> 51218843 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="Shares"> 51218843 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:NetIncomeLoss contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -441401 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -594385 </us-gaap:NetIncomeLoss>
<us-gaap:Depreciation contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 8948 </us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 11727 </us-gaap:Depreciation>
<us-gaap:ShareBasedCompensation contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 270000 </us-gaap:ShareBasedCompensation>
<us-gaap:AmortizationOfIntangibleAssets contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 130404 </us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:AmortizationOfIntangibleAssets contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 130404 </us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 5750 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -2850 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -38238 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInInventories contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -5628 </us-gaap:IncreaseDecreaseInInventories>
<us-gaap:IncreaseDecreaseInInventories contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 209453 </us-gaap:IncreaseDecreaseInInventories>
<us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 682 </us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
<us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 12638 </us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
<actx:IncreaseDecreaseInPrepaidInventoriesOther contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 53375 </actx:IncreaseDecreaseInPrepaidInventoriesOther>
<actx:IncreaseDecreaseInPrepaidInventoriesOther contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 19500 </actx:IncreaseDecreaseInPrepaidInventoriesOther>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 35574 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 53100 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 2148 </us-gaap:IncreaseDecreaseInInterestPayableNet>
<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -19055 </us-gaap:IncreaseDecreaseInInterestPayableNet>
<us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 101591 </us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
<us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 186991 </us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
<actx:IncreaseDecreaseInCustomerDeposit contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 126106 </actx:IncreaseDecreaseInCustomerDeposit>
<actx:IncreaseDecreaseInCustomerDeposit contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -281692 </actx:IncreaseDecreaseInCustomerDeposit>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -76459 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -446263 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -0 </us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 16000 </us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -16000 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:RepaymentsOfDebt contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 158238 </us-gaap:RepaymentsOfDebt>
<us-gaap:RepaymentsOfDebt contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 56400 </us-gaap:RepaymentsOfDebt>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 210000 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 615000 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 163351 </us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 1350 </us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 96866 </us-gaap:RepaymentsOfRelatedPartyDebt>
<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 93474 </us-gaap:RepaymentsOfRelatedPartyDebt>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 118247 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 466476 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 41788 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 4213 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 59367 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD"> 333368 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 101155 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="0" unitRef="USD"> 337581 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:InterestPaidNet contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 6080 </us-gaap:InterestPaidNet>
<us-gaap:InterestPaidNet contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 34318 </us-gaap:InterestPaidNet>
<us-gaap:IncomeTaxesPaidNet contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 1800 </us-gaap:IncomeTaxesPaidNet>
<us-gaap:IncomeTaxesPaidNet contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:IncomeTaxesPaidNet>
<us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_custom_SeriesAPreferredStocksMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_custom_SeriesAPreferredStocksMember" decimals="0" unitRef="USD"> 10 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 51621524 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 516 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 8285066 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -6359450 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1926142 </us-gaap:StockholdersEquity>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 280001 </us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 3 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 209997 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-03-31" decimals="0" unitRef="USD"> 210000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -173117 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31" decimals="0" unitRef="USD"> -173117 </us-gaap:NetIncomeLoss>
<us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_custom_SeriesAPreferredStocksMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_custom_SeriesAPreferredStocksMember" decimals="0" unitRef="USD"> 10 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 51901525 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 519 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 8495063 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -6532567 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31" decimals="0" unitRef="USD"> 1963025 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -268284 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -268284 </us-gaap:NetIncomeLoss>
<us-gaap:SharesOutstanding contextRef="AsOf2022-06-30_custom_SeriesAPreferredStocksMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_custom_SeriesAPreferredStocksMember" decimals="0" unitRef="USD"> 10 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 51901525 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 519 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 8495063 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -6800851 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1694741 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_custom_SeriesAPreferredStocksMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_custom_SeriesAPreferredStocksMember" decimals="0" unitRef="USD"> 10 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 51016524 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 510 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 7400082 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -5514394 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD"> 1886208 </us-gaap:StockholdersEquity>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 485000 </us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 5 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 614995 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-01-012021-03-31" decimals="0" unitRef="USD"> 615000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 120000 </us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 1 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 269999 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-01-012021-03-31" decimals="0" unitRef="USD"> 270000 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -296973 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31" decimals="0" unitRef="USD"> -296973 </us-gaap:NetIncomeLoss>
<us-gaap:SharesOutstanding contextRef="AsOf2021-03-31_custom_SeriesAPreferredStocksMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_custom_SeriesAPreferredStocksMember" decimals="0" unitRef="USD"> 10 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 51621524 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 516 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 8285076 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -5811367 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31" decimals="0" unitRef="USD"> 2474235 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -297412 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -297412 </us-gaap:NetIncomeLoss>
<us-gaap:SharesOutstanding contextRef="AsOf2021-06-30_custom_SeriesAPreferredStocksMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_custom_SeriesAPreferredStocksMember" decimals="0" unitRef="USD"> 10 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 51621524 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 516 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 8285076 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -6108779 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD"> 2176813 </us-gaap:StockholdersEquity>
<us-gaap:NatureOfOperations contextRef="From2022-01-01to2022-06-30">
<p id="xdx_803_eus-gaap--NatureOfOperations_zANbOZozIkQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1 – <span id="xdx_823_ziIjLUef3Sej">Description of Business and Organization</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advanced Container Technologies, Inc. (the “Company”) markets and sells two principal products: (i) beginning in the first quarter of 2021, GrowPods, which are specially modified insulated shipping containers manufactured by GP Solutions, Inc. (“GP”), in which plants, herbs and spices may be grown hydroponically in a controlled environment (“GrowPods”) and (ii) the Medtainer, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The Company also markets and sells products related to GrowPods and the Medtainer. The Company also provides private labeling and branding for purchasers of Medtainers, lighters and other products. Management believes they have one reportable segment given the financial information that is available for review by the chief decision-maker.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was incorporated under the laws of the state of Florida on September 5, 1997. It changed its corporate name to Acology, Inc. on January 9, 2014; to Medtainer, Inc. on August 28, 2018; and to its present name on October 3, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 9, 2020, the Company acquired all of the outstanding shares of Advanced Container Technologies, Inc., a California corporation (“ACT”), from its shareholders pursuant to an Exchange Agreement, dated August 14, 2020, and amended on September 9, 2020 (the “Exchange Agreement”), in exchange for 50,000,000 shares of the Company’s common stock (“Common Stock”). This exchange resulted in ACT’s becoming the wholly owned subsidiary of the Company. In connection with this exchange, the Company acquired a Distributorship Agreement, dated August 6, 2020, by and between ACT and GP (the “Distributorship Agreement”), under which ACT has the exclusive right to purchase GrowPods and related products from GP at prices to be agreed to from time to time and to sell and distribute them within the United States and its territories for an initial term that will expire on December 31, 2025. ACT may renew the Distributorship Agreement indefinitely as long as it purchases in the last calendar year of any term the lesser of (i) 100 GrowPods or (ii) GP’s total output of GrowPods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 27, 2020, the Company incorporated Med X Technologies Inc. (“Med X”) in the State of California, and acquired all of its shares, such that it is the Company’s wholly owned subsidiary. The Company intends to transfer the assets used in its Medtainer and printing businesses to Med X, after which it will conduct all of its operations through Med X and ACT.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:NatureOfOperations>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zollGLVR5sh2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 2 – <span id="xdx_827_znn6vYyGyVTa">Summary of Significant Accounting Policies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zqW2A6COool2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86E_zUL6el5R5KG4">Accounting Principles</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2022, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 18, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zcxWKEM78JS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_865_zdA65Q23RjZ7">Principles of Consolidation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The unaudited consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany balances and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zmoe8ucM1Fx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_860_zOSLsDDBCEMc">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Certain of these estimates could be affected by external conditions, including those unique to the Company’s industries, and general economic conditions. These external conditions could affect the Company’s estimates so as to cause actual results to differ materially from its estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant estimates relied upon in preparing these consolidated financial statements include revenue recognition, accounts receivable reserves, inventory and related reserves, valuations and purchase price allocations related to business combinations, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to intangible assets and goodwill, amortization periods, accrued expenses, share-based compensation, and recoverability of the Company’s net deferred tax assets and any related valuation allowance. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zGIRjGnlrRHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86B_zjEyV9JnwFKj">Cash and Cash Equivalents</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of 3 months or less to be cash equivalents. The Company had <span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zwtiWKJTAf3j" title="Cash Equivalents, at Carrying Value"><span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20211231_zGizDVdrSuBa" title="Cash Equivalents, at Carrying Value">no</span></span> cash equivalents at June 30, 2022, or December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--ReceivablesPolicyTextBlock_zJvs0RNziefi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_868_zxBImV6RKpy3">Accounts Receivable</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Included in accounts receivable on the consolidated balance sheets are amounts primarily related to customers. The Company estimates losses on receivables based on known troubled accounts and historical experience of losses incurred. Receivables are considered impaired and written off when it is probable that all contractual payments due will not be collected in accordance with the terms of the related agreement. Based upon experience and the judgment of management, the provision for doubtful accounts was $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20220630_zkOI2m8BzpUd">5,750</span> for the six months ended June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zptZuuOMPIXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_865_zl35FtuPdVWj">Inventories</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, which consist of products held for resale, are stated at the lower of cost (determined using the first-in first-out method) and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs to complete and dispose of the product. If the Company identifies excess, obsolete or unsalable items, its inventories are written down to their realizable value in the period in which the impairment is first identified. Shipping and handling costs incurred for inventory purchases and product shipments are recorded in cost of sales in the Company’s consolidated statements of operations. As of June 30, 2022, no inventory reserves were considered necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zojFU8tthKgk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86E_zFDNFACpHks6">Property and Equipment</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets. Furniture and fixtures are depreciated over the useful life of <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z5iXE9RFcOW9" title="Useful life, term">7</span> years. Machinery, equipment, and computers are depreciated over the useful life of <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zEkUMmHFebih" title="Useful life, term">3</span> to <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_znnIsWlaEJf1" title="Useful life, term">7</span> years. Leasehold improvements are depreciated over <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember_z8WJyWPVO8bh" title="Useful life, term">2</span> years and were fully depreciated as of June 30, 2022. Expenditures for additions and improvements are capitalized and repairs and maintenance are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zDK1C5uYzzFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_869_zeRqUsqbP3L3">Goodwill and Intangible Assets</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill and intangible assets that have indefinite useful lives are not amortized but are evaluated for impairment annually or whenever events or changes in circumstances indicate that their carrying value may not be recoverable. The Company records intangible assets at fair value when they are acquired and they are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. The impairment test consists of a comparison of the fair value of the indefinite-lived intangible asset with its carrying amount. If the carrying amount of an intangible asset exceeds its fair value, an impairment loss will be recorded in the consolidated statements of operations in an amount equal to that excess. The Company amortizes its intangible assets that have finite lives using either the straight-line method or based upon estimated future cash flows to approximate the pattern in which the economic benefit of the assets will be utilized. Amortization is recorded over estimated useful lives ranging from <span id="xdx_905_ecustom--AmortizationEstimatedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zCxvPvZUao6k" title="Amortization estimated useful lives">5</span> to <span id="xdx_900_ecustom--AmortizationEstimatedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zmdc5IEn6w34" title="Amortization estimated useful lives">20</span> years. The Company records intangible assets at fair value, estimated using a discounted-cash-flow approach.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews intangible assets subject to amortization at least annually to determine whether any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that would indicate impairment and trigger a more frequent than quarterly impairment assessment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset or an adverse action or assessment by a regulator. If the carrying value of an intangible asset exceeds its undiscounted cash flows, the Company will write down the carrying value to its fair value in the period identified. The Company generally calculates fair value as the present value of estimated future cash flows to be generated by the asset using a risk-adjusted discount rate. If the estimate of an intangible asset’s remaining useful life is changed, the Company will amortize its remaining carrying value prospectively over its revised remaining useful life. The Company has conducted its annual impairment test of goodwill during the fourth quarter of each year. The estimation of fair value requires significant judgment. There was <span id="xdx_90E_eus-gaap--GoodwillAndIntangibleAssetImpairment_pp0p0_do_c20220101__20220630_zneJn7F63RJh" title="Goodwill and Intangible Asset Impairment"><span id="xdx_906_eus-gaap--GoodwillAndIntangibleAssetImpairment_pp0p0_do_c20210101__20210630_zVbUOLsJRc9g" title="Goodwill and Intangible Asset Impairment">no</span></span> impairment of intangible assets, long-lived assets or goodwill during the six-month periods ended June 30, 2022, or June 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any loss resulting from an impairment test will be reflected in operating income in the Company’s consolidated statements of operations. The annual impairment testing process is subjective and requires judgment at many points. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges for these assets not previously recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zKgFBfR9We6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_868_z9ToKXuUcZK5">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, <i>Revenue from Contracts with Customers</i> (Topic 606), as amended. This standard requires a company to recognize revenues when it transfers goods or services to customers in an amount that reflects the consideration that it expects to receive for them.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under ASC 606, Company recognizes revenue when a customer obtains control of promised goods or services or when they are shipped to a customer, in an amount that reflects the consideration that it expects to receive in exchange for them. The Company recognizes revenues following the five-step model prescribed under ASC 606: (a) it identifies a contract with a customer; (b) it identifies the performance obligations in the contract; (c) it determines the transaction price; (d) it allocates the transaction price to the performance obligations in the contract; and (e) it recognizes revenues when (or as) it satisfies its performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues from product sales are recognized when a customer obtains control of the Company’s product, which occurs at a point in time, typically upon shipment to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have been recognized is 1 year or less or the amount is immaterial.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue from sales of items sold by the Company for the three months ended June 30, 2022, and June 30, 2021, and the percentage of sales allocable to each item to the Company’s total revenues were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zmvlkbGqmeda" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details) - Disaggregation of revenue"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B3_zD0QBqKfVgs8" style="display: none">Schedule of revenue from sales of items sold</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">GrowPods and related products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zO3AzxYfD9P2" style="width: 11%; text-align: right" title="Revenues">202,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zW16ro0sxcJ9" title="Concentration Risk, Percentage">27</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_z9M3dZugRPQc" style="width: 11%; text-align: right" title="Revenues">145,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zKsBvshYWDQ3" title="Concentration Risk, Percentage">19</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Medtainers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedtainersMember_zAQK5zpz49Z3" style="text-align: right" title="Revenues">188,655</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zxOpb1nrT0Ad" title="Concentration Risk, Percentage">26</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedtainersMember_zbuNHNHpWXXa" style="text-align: right" title="Revenues">273,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zrjDflU1QYll" title="Concentration Risk, Percentage">36</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Lighters</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--LightersMember_zmQUKfdwj6kc" style="text-align: right" title="Revenues">174,286</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_z66XLtW628U6" title="Concentration Risk, Percentage">24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--LightersMember_zKwWikhVliri" style="text-align: right" title="Revenues">129,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zD8XsZ9KLOhf" title="Concentration Risk, Percentage">17</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Humidity pack inserts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zpi7D4khSaY7" style="text-align: right" title="Revenues">92,884</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_z7oPPHR2VZ7d" title="Concentration Risk, Percentage">13</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zaffrXVTtgM3" style="text-align: right" title="Revenues">86,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_ztrFK2lubzY2" title="Concentration Risk, Percentage">11</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Plastic lighter holders</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zzyRN7v6sHH7" style="text-align: right" title="Revenues">37,640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_ztljBqE1c2yh" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zGBquvb5He3h" style="text-align: right" title="Revenues">35,682</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_z81XvVjDyv6h" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Printing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--PrintingMember_zYTcpF7Otfr9" style="text-align: right" title="Revenues">22,450</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_z2mLNdjftEha" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--PrintingMember_zD7v8qMP1WE6" style="text-align: right" title="Revenues">14,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zxktW7s6mV3k" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping charges</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zYt8Zk44gXe1" style="text-align: right" title="Revenues">18,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zKzHG4NerVje" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_z6IjNOKjv6Tc" style="text-align: right" title="Revenues">21,790</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zK6PZGI0YIF1" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Jars</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--JarsMember_zeUV3aJPNnEj" style="text-align: right" title="Revenues">4,175</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zMOmfDfjnlC9" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--JarsMember_zQRW6OOOLCTd" style="text-align: right" title="Revenues">8,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zQIr7nndH1Tl" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--OthersMember_z7qYDjMhgb8b" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">(1,920</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_z3Jm7PMQD1J6" title="Concentration Risk, Percentage">0</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--OthersMember_zU6OeJKVLWHe" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">42,738</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_ztbj6VxDNnD3" title="Concentration Risk, Percentage">6</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20220401__20220630_zZUc1z2y6ogc" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">739,342</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zEu4IhyMKmT3" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20210401__20210630_za7glrT53kwk" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">758,572</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zIOeL4biGFDh" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue from sales of items sold by the Company for the six months ended June 30, 2022, and June 30, 2021, and the percentage of sales allocable to each item to the Company’s total revenues were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Lighters</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--LightersMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">444,347</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zlMkCY0JlD4g" title="Concentration Risk, Percentage">27</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--LightersMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">211,859</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zHHvKWrAa9m7" title="Concentration Risk, Percentage">8</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Medtainers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedtainersMember_pp0p0" style="text-align: right" title="Revenues">410,896</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zVcKcNyk62B4" title="Concentration Risk, Percentage">25</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedtainersMember_pp0p0" style="text-align: right" title="Revenues">498,745</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zr7BwblbNNhg" title="Concentration Risk, Percentage">19</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GrowPods and related products</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_pp0p0" style="text-align: right" title="Revenues">399,650</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_z8MnGzy1kECk" title="Concentration Risk, Percentage">24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_pp0p0" style="text-align: right" title="Revenues">1,470,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zNDIUJCcC2nh" title="Concentration Risk, Percentage">56</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Humidity pack inserts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_pp0p0" style="text-align: right" title="Revenues">173,418</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zANptztdsEua" title="Concentration Risk, Percentage">10</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_pp0p0" style="text-align: right" title="Revenues">237,663</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zSBF3qa1fWda" title="Concentration Risk, Percentage">9</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Plastic lighter holders</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_pp0p0" style="text-align: right" title="Revenues">78,198</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_ztFNVEWpCPjh" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_pp0p0" style="text-align: right" title="Revenues">65,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zUYdN8dOwqyd" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Printing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--PrintingMember_pp0p0" style="text-align: right" title="Revenues">55,547</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zkFK4juLByTa" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--PrintingMember_pp0p0" style="text-align: right" title="Revenues">23,980</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zFTdRSNfEIKd" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Others</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--OthersMember_pp0p0" style="text-align: right" title="Revenues">49,003</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_zsAm9jA3b9Ij" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--OthersMember_pp0p0" style="text-align: right" title="Revenues">67,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_zVBEmRQQAaVd" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shipping charges</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_pp0p0" style="text-align: right" title="Revenues">42,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zoZLVi4B9zD1" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_pp0p0" style="text-align: right" title="Revenues">39,633</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zs7nVWcVYdga" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Jars</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--JarsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">11,875</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zNdU8F5I4Fog" title="Concentration Risk, Percentage">1</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--JarsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">17,040</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zVIkNhjJLEih" title="Concentration Risk, Percentage">1</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220101__20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,665,490</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zJbh6bZwoj79" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">2,631,530</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_z0hiM7aw5Jje" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zNGP8vdI8bEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below presents the customer deposits payable balance and the significant activity affecting customer deposits during the period ended June 30, 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeTextBlock_zpK59YkYe72h" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of customer deposits payable balance and the significant activity affecting customer deposits"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zVuH1vJmZzI" style="display: none">Schedule of customer deposits</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 83%">Balance at December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--CustomerDepositsPayable_iS_c20220101__20220630_zHyBeOvveMZ6" style="width: 13%; text-align: right" title="Customer deposit at, beginning">361,230</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">New customer deposits received</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromDepositsFromCustomers_c20220101__20220630_z8bCZCNtGuV9" style="text-align: right" title="New customer deposits received">591,101</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Revenue recognized from customer deposits</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_iN_di_c20220101__20220630_zxGeH3C7vt4b" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from customer deposits">(464,995</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at June 30, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--CustomerDepositsPayable_iE_c20220101__20220630_z6xgYAZaOvcl" style="border-bottom: Black 2.5pt double; text-align: right" title="Customer deposit at ending">487,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zx6NVqnU13Z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJirwQQiICTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_864_zxmftDUpHe6h">Share-Based Payments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 718, <i>Compensation – Stock Compensation</i>, prescribes accounting and reporting standards for all share-based payment transactions. The Company follows FASB guidance related to equity-based payments, for both employees and non-employees, which requires that equity-based compensation be accounted for using a fair value method and recognized as expense in the accompanying consolidated statements of operations. Equity-based compensation expense is recognized as compensation expense over the applicable service or vesting period (see Note 7).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zrvL6JGxSfw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_860_zBcLtSIcsZC9">Fair Value Measurements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has adopted ASC Topic 820, <i>Fair Value Measurements,</i> which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, is carried on a historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of the Company’s short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features, such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 also establishes a fair-value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC Topic 820 describes three levels of inputs that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt">Level 1 - Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt">Level 2 - Quoted prices for similar assets and liabilities in active markets or inputs that are observable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt">Level 3 - Inputs that are unobservable (for example, cash flow modeling inputs based on assumptions).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt"> </p> <p id="xdx_845_eus-gaap--AdvertisingCostsPolicyTextBlock_zbACY3R9wxw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_860_zktalX6oIAU4">Advertising</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising and marketing expenses are charged to operations as incurred. These expenses totaled $<span id="xdx_900_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20220630_pp0p0" title="Advertising and marketing expenses">77,991</span> and $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20210101__20210630_pp0p0" title="Advertising and marketing expenses">32,431</span> for the six months ended June 30, 2022, and June 30, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zLkTa3fGBS94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86A_zApMNCsxsLM1">Income Taxes</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, <i>Income Taxes</i>. Under this method, income tax expense is recognized for (a) taxes payable or refundable for the current year and (b) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if, based on the weight of the available positive and negative evidence, it is more likely than not that some portion or all the deferred tax assets will not be realized. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 740-10-30 clarifies accounting for uncertainty in income taxes recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has no material uncertain tax positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zlFymcdQEH03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86B_zWYsZEqiAO0k">Concentration of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which at times may exceed the federal deposit insurance coverage of $250,000. The Company has not experienced losses on these accounts and believes that it is not exposed to significant risks on such accounts. The Company has not experienced losses on accounts receivable and the Company believes that it is not exposed to significant risks with respect to them.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zCzFFedOXpYb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_866_zXmZjqf9rJs6">Loss per Share</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The basic loss per share is calculated by dividing the Company’s net loss attributable to common stockholders by the weighted average number of common shares outstanding during the year. The diluted loss per share is calculated by dividing the Company’s net loss attributable to common stockholders by the diluted weighted average number of shares outstanding during the year. The potentially dilutive stock options on the Company’s common stock were not considered in the computation of diluted net loss per share as they would be anti-dilutive. <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20220101__20220630_zUCWPuBwH87k" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20210101__20210630_zfYblPmeCsa" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">No</span></span> dilutive effective as calculated for the three and six months ended June 30, 2022, and June 30, 2021, as the Company reported a net loss for each period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLtkqtP3Kh8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_866_zbFIO2eOrVic">Recent Accounting Pronouncements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows ASU 2016-02, <i>Leases (Topic 842)</i>, which requires recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and a corresponding right-of-use asset on a balance sheet for most leases, along with requirements for enhanced disclosures to enable the assessment of the amount, timing and uncertainty of cash flows arising from leasing arrangements. The Company and a related party entered into a building lease effective on September 1, 2018, which had a one-year term that expired on August 31, 2019, was renewed for a one-year term that expired on August 31, 2020, was renewed for a one-year term that expired on August 31, 2021, and has been renewed for a one-year term that expires August 31, 2022, at a monthly rent of $<span id="xdx_905_ecustom--MonthlyRent_c20220101__20220630_zfVHrpmxrR86" title="Monthly Rent">9,791</span>. On March 23, 2021, the Company and an unrelated party entered into a lease of premises in Tulsa, Oklahoma, having a monthly rental of $5,500. The lease has a one-year term that expired on March 31, 2022, and was renewed for a one-year term at the same rent. The Company is obligated to pay all taxes, insurance, operating expenses, repairs and certain maintenance costs and utilities. Because each of these leases has a term of 12 months or less and there is no assurance the Company will remain in the building locations after the leases have expired, the Company has concluded that this ASU does not apply to these leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020, FASB issued ASU 2020-06, “<i>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.</i>” For convertible instruments, FASB reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) those issued with substantial premiums for which the premiums are recorded as paid-in capital. FASB decided to amend the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. FASB observed that the application of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically similar contracts as equity. FASB also decided to improve and amend the related earnings per share guidance. The amendments in this update are effective for public business entities that meet the definition of an SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Management is currently evaluating the potential impact of this new standard.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, FASB issued ASU 2019-12, <i>Income Taxes, </i>which simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in ASC 740 related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The guidance is effective for fiscal years beginning after December 31, 2021, and interim periods within that year. The adoption did not have any material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, FASB issued ASU 2016-13 regarding ASC Topic 326, “<i>Measurement of Credit Losses on Financial Instruments</i>.” This pronouncement changes the impairment model for most financial assets and will require the use of an “expected loss” model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. Subsequently, FASB issued an amendment to clarify the implementation dates and items that fall within the scope of this pronouncement. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Management is currently evaluating the effect on the Company’s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not believe there are any other recently issued, but not yet effective, accounting standards that would have a significant impact on the Company’s financial position or results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>
</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_845_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zqW2A6COool2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86E_zUL6el5R5KG4">Accounting Principles</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2022, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 18, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zcxWKEM78JS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_865_zdA65Q23RjZ7">Principles of Consolidation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The unaudited consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All intercompany balances and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84E_eus-gaap--UseOfEstimates_zmoe8ucM1Fx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_860_zOSLsDDBCEMc">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Certain of these estimates could be affected by external conditions, including those unique to the Company’s industries, and general economic conditions. These external conditions could affect the Company’s estimates so as to cause actual results to differ materially from its estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant estimates relied upon in preparing these consolidated financial statements include revenue recognition, accounts receivable reserves, inventory and related reserves, valuations and purchase price allocations related to business combinations, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to intangible assets and goodwill, amortization periods, accrued expenses, share-based compensation, and recoverability of the Company’s net deferred tax assets and any related valuation allowance. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:UseOfEstimates>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zGIRjGnlrRHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86B_zjEyV9JnwFKj">Cash and Cash Equivalents</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of 3 months or less to be cash equivalents. The Company had <span id="xdx_90C_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20220630_zwtiWKJTAf3j" title="Cash Equivalents, at Carrying Value"><span id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20211231_zGizDVdrSuBa" title="Cash Equivalents, at Carrying Value">no</span></span> cash equivalents at June 30, 2022, or December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:CashEquivalentsAtCarryingValue>
<us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 0 </us-gaap:CashEquivalentsAtCarryingValue>
<us-gaap:ReceivablesPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_849_eus-gaap--ReceivablesPolicyTextBlock_zJvs0RNziefi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_868_zxBImV6RKpy3">Accounts Receivable</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Included in accounts receivable on the consolidated balance sheets are amounts primarily related to customers. The Company estimates losses on receivables based on known troubled accounts and historical experience of losses incurred. Receivables are considered impaired and written off when it is probable that all contractual payments due will not be collected in accordance with the terms of the related agreement. Based upon experience and the judgment of management, the provision for doubtful accounts was $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20220630_zkOI2m8BzpUd">5,750</span> for the six months ended June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:ReceivablesPolicyTextBlock>
<us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 5750 </us-gaap:AllowanceForDoubtfulAccountsReceivable>
<us-gaap:InventoryPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zptZuuOMPIXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_865_zl35FtuPdVWj">Inventories</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories, which consist of products held for resale, are stated at the lower of cost (determined using the first-in first-out method) and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs to complete and dispose of the product. If the Company identifies excess, obsolete or unsalable items, its inventories are written down to their realizable value in the period in which the impairment is first identified. Shipping and handling costs incurred for inventory purchases and product shipments are recorded in cost of sales in the Company’s consolidated statements of operations. As of June 30, 2022, no inventory reserves were considered necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:InventoryPolicyTextBlock>
<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zojFU8tthKgk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86E_zFDNFACpHks6">Property and Equipment</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets. Furniture and fixtures are depreciated over the useful life of <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z5iXE9RFcOW9" title="Useful life, term">7</span> years. Machinery, equipment, and computers are depreciated over the useful life of <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zEkUMmHFebih" title="Useful life, term">3</span> to <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_znnIsWlaEJf1" title="Useful life, term">7</span> years. Leasehold improvements are depreciated over <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdsAndLeaseholdImprovementsMember_z8WJyWPVO8bh" title="Useful life, term">2</span> years and were fully depreciated as of June 30, 2022. Expenditures for additions and improvements are capitalized and repairs and maintenance are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2022-01-012022-06-30_us-gaap_FurnitureAndFixturesMember"> P7Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2022-01-012022-06-30_srt_MinimumMember_us-gaap_ComputerEquipmentMember"> P3Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2022-01-012022-06-30_srt_MaximumMember_us-gaap_ComputerEquipmentMember"> P7Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2022-01-012022-06-30_us-gaap_LeaseholdsAndLeaseholdImprovementsMember"> P2Y </us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zDK1C5uYzzFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_869_zeRqUsqbP3L3">Goodwill and Intangible Assets</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill and intangible assets that have indefinite useful lives are not amortized but are evaluated for impairment annually or whenever events or changes in circumstances indicate that their carrying value may not be recoverable. The Company records intangible assets at fair value when they are acquired and they are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. The impairment test consists of a comparison of the fair value of the indefinite-lived intangible asset with its carrying amount. If the carrying amount of an intangible asset exceeds its fair value, an impairment loss will be recorded in the consolidated statements of operations in an amount equal to that excess. The Company amortizes its intangible assets that have finite lives using either the straight-line method or based upon estimated future cash flows to approximate the pattern in which the economic benefit of the assets will be utilized. Amortization is recorded over estimated useful lives ranging from <span id="xdx_905_ecustom--AmortizationEstimatedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zCxvPvZUao6k" title="Amortization estimated useful lives">5</span> to <span id="xdx_900_ecustom--AmortizationEstimatedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zmdc5IEn6w34" title="Amortization estimated useful lives">20</span> years. The Company records intangible assets at fair value, estimated using a discounted-cash-flow approach.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews intangible assets subject to amortization at least annually to determine whether any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that would indicate impairment and trigger a more frequent than quarterly impairment assessment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset or an adverse action or assessment by a regulator. If the carrying value of an intangible asset exceeds its undiscounted cash flows, the Company will write down the carrying value to its fair value in the period identified. The Company generally calculates fair value as the present value of estimated future cash flows to be generated by the asset using a risk-adjusted discount rate. If the estimate of an intangible asset’s remaining useful life is changed, the Company will amortize its remaining carrying value prospectively over its revised remaining useful life. The Company has conducted its annual impairment test of goodwill during the fourth quarter of each year. The estimation of fair value requires significant judgment. There was <span id="xdx_90E_eus-gaap--GoodwillAndIntangibleAssetImpairment_pp0p0_do_c20220101__20220630_zneJn7F63RJh" title="Goodwill and Intangible Asset Impairment"><span id="xdx_906_eus-gaap--GoodwillAndIntangibleAssetImpairment_pp0p0_do_c20210101__20210630_zVbUOLsJRc9g" title="Goodwill and Intangible Asset Impairment">no</span></span> impairment of intangible assets, long-lived assets or goodwill during the six-month periods ended June 30, 2022, or June 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any loss resulting from an impairment test will be reflected in operating income in the Company’s consolidated statements of operations. The annual impairment testing process is subjective and requires judgment at many points. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges for these assets not previously recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
<actx:AmortizationEstimatedUsefulLives contextRef="From2022-01-012022-06-30_srt_MinimumMember"> P5Y </actx:AmortizationEstimatedUsefulLives>
<actx:AmortizationEstimatedUsefulLives contextRef="From2022-01-012022-06-30_srt_MaximumMember"> P20Y </actx:AmortizationEstimatedUsefulLives>
<us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:GoodwillAndIntangibleAssetImpairment>
<us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:GoodwillAndIntangibleAssetImpairment>
<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zKgFBfR9We6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_868_z9ToKXuUcZK5">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, <i>Revenue from Contracts with Customers</i> (Topic 606), as amended. This standard requires a company to recognize revenues when it transfers goods or services to customers in an amount that reflects the consideration that it expects to receive for them.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under ASC 606, Company recognizes revenue when a customer obtains control of promised goods or services or when they are shipped to a customer, in an amount that reflects the consideration that it expects to receive in exchange for them. The Company recognizes revenues following the five-step model prescribed under ASC 606: (a) it identifies a contract with a customer; (b) it identifies the performance obligations in the contract; (c) it determines the transaction price; (d) it allocates the transaction price to the performance obligations in the contract; and (e) it recognizes revenues when (or as) it satisfies its performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues from product sales are recognized when a customer obtains control of the Company’s product, which occurs at a point in time, typically upon shipment to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have been recognized is 1 year or less or the amount is immaterial.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue from sales of items sold by the Company for the three months ended June 30, 2022, and June 30, 2021, and the percentage of sales allocable to each item to the Company’s total revenues were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zmvlkbGqmeda" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details) - Disaggregation of revenue"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B3_zD0QBqKfVgs8" style="display: none">Schedule of revenue from sales of items sold</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">GrowPods and related products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zO3AzxYfD9P2" style="width: 11%; text-align: right" title="Revenues">202,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zW16ro0sxcJ9" title="Concentration Risk, Percentage">27</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_z9M3dZugRPQc" style="width: 11%; text-align: right" title="Revenues">145,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zKsBvshYWDQ3" title="Concentration Risk, Percentage">19</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Medtainers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedtainersMember_zAQK5zpz49Z3" style="text-align: right" title="Revenues">188,655</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zxOpb1nrT0Ad" title="Concentration Risk, Percentage">26</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedtainersMember_zbuNHNHpWXXa" style="text-align: right" title="Revenues">273,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zrjDflU1QYll" title="Concentration Risk, Percentage">36</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Lighters</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--LightersMember_zmQUKfdwj6kc" style="text-align: right" title="Revenues">174,286</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_z66XLtW628U6" title="Concentration Risk, Percentage">24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--LightersMember_zKwWikhVliri" style="text-align: right" title="Revenues">129,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zD8XsZ9KLOhf" title="Concentration Risk, Percentage">17</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Humidity pack inserts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zpi7D4khSaY7" style="text-align: right" title="Revenues">92,884</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_z7oPPHR2VZ7d" title="Concentration Risk, Percentage">13</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zaffrXVTtgM3" style="text-align: right" title="Revenues">86,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_ztrFK2lubzY2" title="Concentration Risk, Percentage">11</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Plastic lighter holders</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zzyRN7v6sHH7" style="text-align: right" title="Revenues">37,640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_ztljBqE1c2yh" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zGBquvb5He3h" style="text-align: right" title="Revenues">35,682</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_z81XvVjDyv6h" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Printing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--PrintingMember_zYTcpF7Otfr9" style="text-align: right" title="Revenues">22,450</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_z2mLNdjftEha" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--PrintingMember_zD7v8qMP1WE6" style="text-align: right" title="Revenues">14,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zxktW7s6mV3k" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping charges</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zYt8Zk44gXe1" style="text-align: right" title="Revenues">18,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zKzHG4NerVje" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_z6IjNOKjv6Tc" style="text-align: right" title="Revenues">21,790</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zK6PZGI0YIF1" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Jars</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--JarsMember_zeUV3aJPNnEj" style="text-align: right" title="Revenues">4,175</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zMOmfDfjnlC9" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--JarsMember_zQRW6OOOLCTd" style="text-align: right" title="Revenues">8,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zQIr7nndH1Tl" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--OthersMember_z7qYDjMhgb8b" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">(1,920</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_z3Jm7PMQD1J6" title="Concentration Risk, Percentage">0</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--OthersMember_zU6OeJKVLWHe" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">42,738</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_ztbj6VxDNnD3" title="Concentration Risk, Percentage">6</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20220401__20220630_zZUc1z2y6ogc" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">739,342</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zEu4IhyMKmT3" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20210401__20210630_za7glrT53kwk" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">758,572</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zIOeL4biGFDh" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue from sales of items sold by the Company for the six months ended June 30, 2022, and June 30, 2021, and the percentage of sales allocable to each item to the Company’s total revenues were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Lighters</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--LightersMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">444,347</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zlMkCY0JlD4g" title="Concentration Risk, Percentage">27</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--LightersMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">211,859</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zHHvKWrAa9m7" title="Concentration Risk, Percentage">8</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Medtainers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedtainersMember_pp0p0" style="text-align: right" title="Revenues">410,896</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zVcKcNyk62B4" title="Concentration Risk, Percentage">25</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedtainersMember_pp0p0" style="text-align: right" title="Revenues">498,745</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zr7BwblbNNhg" title="Concentration Risk, Percentage">19</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GrowPods and related products</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_pp0p0" style="text-align: right" title="Revenues">399,650</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_z8MnGzy1kECk" title="Concentration Risk, Percentage">24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_pp0p0" style="text-align: right" title="Revenues">1,470,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zNDIUJCcC2nh" title="Concentration Risk, Percentage">56</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Humidity pack inserts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_pp0p0" style="text-align: right" title="Revenues">173,418</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zANptztdsEua" title="Concentration Risk, Percentage">10</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_pp0p0" style="text-align: right" title="Revenues">237,663</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zSBF3qa1fWda" title="Concentration Risk, Percentage">9</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Plastic lighter holders</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_pp0p0" style="text-align: right" title="Revenues">78,198</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_ztFNVEWpCPjh" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_pp0p0" style="text-align: right" title="Revenues">65,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zUYdN8dOwqyd" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Printing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--PrintingMember_pp0p0" style="text-align: right" title="Revenues">55,547</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zkFK4juLByTa" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--PrintingMember_pp0p0" style="text-align: right" title="Revenues">23,980</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zFTdRSNfEIKd" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Others</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--OthersMember_pp0p0" style="text-align: right" title="Revenues">49,003</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_zsAm9jA3b9Ij" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--OthersMember_pp0p0" style="text-align: right" title="Revenues">67,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_zVBEmRQQAaVd" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shipping charges</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_pp0p0" style="text-align: right" title="Revenues">42,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zoZLVi4B9zD1" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_pp0p0" style="text-align: right" title="Revenues">39,633</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zs7nVWcVYdga" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Jars</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--JarsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">11,875</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zNdU8F5I4Fog" title="Concentration Risk, Percentage">1</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--JarsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">17,040</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zVIkNhjJLEih" title="Concentration Risk, Percentage">1</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220101__20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,665,490</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zJbh6bZwoj79" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">2,631,530</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_z0hiM7aw5Jje" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zNGP8vdI8bEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below presents the customer deposits payable balance and the significant activity affecting customer deposits during the period ended June 30, 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeTextBlock_zpK59YkYe72h" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of customer deposits payable balance and the significant activity affecting customer deposits"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zVuH1vJmZzI" style="display: none">Schedule of customer deposits</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 83%">Balance at December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--CustomerDepositsPayable_iS_c20220101__20220630_zHyBeOvveMZ6" style="width: 13%; text-align: right" title="Customer deposit at, beginning">361,230</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">New customer deposits received</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromDepositsFromCustomers_c20220101__20220630_z8bCZCNtGuV9" style="text-align: right" title="New customer deposits received">591,101</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Revenue recognized from customer deposits</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_iN_di_c20220101__20220630_zxGeH3C7vt4b" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from customer deposits">(464,995</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at June 30, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--CustomerDepositsPayable_iE_c20220101__20220630_z6xgYAZaOvcl" style="border-bottom: Black 2.5pt double; text-align: right" title="Customer deposit at ending">487,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zx6NVqnU13Z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:RevenueRecognitionPolicyTextBlock>
<us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--DisaggregationOfRevenueTableTextBlock_zmvlkbGqmeda" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details) - Disaggregation of revenue"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B3_zD0QBqKfVgs8" style="display: none">Schedule of revenue from sales of items sold</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">GrowPods and related products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zO3AzxYfD9P2" style="width: 11%; text-align: right" title="Revenues">202,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zW16ro0sxcJ9" title="Concentration Risk, Percentage">27</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_z9M3dZugRPQc" style="width: 11%; text-align: right" title="Revenues">145,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zKsBvshYWDQ3" title="Concentration Risk, Percentage">19</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Medtainers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedtainersMember_zAQK5zpz49Z3" style="text-align: right" title="Revenues">188,655</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zxOpb1nrT0Ad" title="Concentration Risk, Percentage">26</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedtainersMember_zbuNHNHpWXXa" style="text-align: right" title="Revenues">273,961</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zrjDflU1QYll" title="Concentration Risk, Percentage">36</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Lighters</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--LightersMember_zmQUKfdwj6kc" style="text-align: right" title="Revenues">174,286</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_z66XLtW628U6" title="Concentration Risk, Percentage">24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--LightersMember_zKwWikhVliri" style="text-align: right" title="Revenues">129,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zD8XsZ9KLOhf" title="Concentration Risk, Percentage">17</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Humidity pack inserts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zpi7D4khSaY7" style="text-align: right" title="Revenues">92,884</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_z7oPPHR2VZ7d" title="Concentration Risk, Percentage">13</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zaffrXVTtgM3" style="text-align: right" title="Revenues">86,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_ztrFK2lubzY2" title="Concentration Risk, Percentage">11</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Plastic lighter holders</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zzyRN7v6sHH7" style="text-align: right" title="Revenues">37,640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_ztljBqE1c2yh" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zGBquvb5He3h" style="text-align: right" title="Revenues">35,682</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_z81XvVjDyv6h" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Printing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--PrintingMember_zYTcpF7Otfr9" style="text-align: right" title="Revenues">22,450</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_z2mLNdjftEha" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--PrintingMember_zD7v8qMP1WE6" style="text-align: right" title="Revenues">14,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zxktW7s6mV3k" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping charges</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zYt8Zk44gXe1" style="text-align: right" title="Revenues">18,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zKzHG4NerVje" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_z6IjNOKjv6Tc" style="text-align: right" title="Revenues">21,790</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zK6PZGI0YIF1" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Jars</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--JarsMember_zeUV3aJPNnEj" style="text-align: right" title="Revenues">4,175</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zMOmfDfjnlC9" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--JarsMember_zQRW6OOOLCTd" style="text-align: right" title="Revenues">8,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zQIr7nndH1Tl" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20220401__20220630__srt--ProductOrServiceAxis__custom--OthersMember_z7qYDjMhgb8b" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">(1,920</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_z3Jm7PMQD1J6" title="Concentration Risk, Percentage">0</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20210401__20210630__srt--ProductOrServiceAxis__custom--OthersMember_zU6OeJKVLWHe" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">42,738</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_ztbj6VxDNnD3" title="Concentration Risk, Percentage">6</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pp0p0_c20220401__20220630_zZUc1z2y6ogc" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">739,342</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zEu4IhyMKmT3" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20210401__20210630_za7glrT53kwk" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">758,572</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zIOeL4biGFDh" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue from sales of items sold by the Company for the six months ended June 30, 2022, and June 30, 2021, and the percentage of sales allocable to each item to the Company’s total revenues were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenues</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Lighters</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--LightersMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">444,347</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zlMkCY0JlD4g" title="Concentration Risk, Percentage">27</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--LightersMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">211,859</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--LightersMember_zHHvKWrAa9m7" title="Concentration Risk, Percentage">8</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Medtainers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedtainersMember_pp0p0" style="text-align: right" title="Revenues">410,896</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zVcKcNyk62B4" title="Concentration Risk, Percentage">25</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedtainersMember_pp0p0" style="text-align: right" title="Revenues">498,745</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--MedtainersMember_zr7BwblbNNhg" title="Concentration Risk, Percentage">19</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GrowPods and related products</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_pp0p0" style="text-align: right" title="Revenues">399,650</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_z8MnGzy1kECk" title="Concentration Risk, Percentage">24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_pp0p0" style="text-align: right" title="Revenues">1,470,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--GrowPodsAndRelatedItemsMember_zNDIUJCcC2nh" title="Concentration Risk, Percentage">56</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Humidity pack inserts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_pp0p0" style="text-align: right" title="Revenues">173,418</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zANptztdsEua" title="Concentration Risk, Percentage">10</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_pp0p0" style="text-align: right" title="Revenues">237,663</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--HumidityPackInsertsMember_zSBF3qa1fWda" title="Concentration Risk, Percentage">9</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Plastic lighter holders</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_pp0p0" style="text-align: right" title="Revenues">78,198</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_ztFNVEWpCPjh" title="Concentration Risk, Percentage">5</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_pp0p0" style="text-align: right" title="Revenues">65,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PlasticLighterHoldersMember_zUYdN8dOwqyd" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Printing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--PrintingMember_pp0p0" style="text-align: right" title="Revenues">55,547</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zkFK4juLByTa" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--PrintingMember_pp0p0" style="text-align: right" title="Revenues">23,980</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--PrintingMember_zFTdRSNfEIKd" title="Concentration Risk, Percentage">1</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Others</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--OthersMember_pp0p0" style="text-align: right" title="Revenues">49,003</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_zsAm9jA3b9Ij" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--OthersMember_pp0p0" style="text-align: right" title="Revenues">67,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OthersMember_zVBEmRQQAaVd" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shipping charges</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_pp0p0" style="text-align: right" title="Revenues">42,556</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zoZLVi4B9zD1" title="Concentration Risk, Percentage">3</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--ShippingChargesMember_pp0p0" style="text-align: right" title="Revenues">39,633</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--ShippingChargesMember_zs7nVWcVYdga" title="Concentration Risk, Percentage">2</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Jars</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20220101__20220630__srt--ProductOrServiceAxis__custom--JarsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">11,875</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zNdU8F5I4Fog" title="Concentration Risk, Percentage">1</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20210101__20210630__srt--ProductOrServiceAxis__custom--JarsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">17,040</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--JarsMember_zVIkNhjJLEih" title="Concentration Risk, Percentage">1</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220101__20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,665,490</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_zJbh6bZwoj79" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">2,631,530</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--AllProductsMember_z0hiM7aw5Jje" title="Concentration Risk, Percentage">100</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
</us-gaap:DisaggregationOfRevenueTableTextBlock>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_GrowPodsAndRelatedItemsMember" decimals="0" unitRef="USD"> 202500 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_GrowPodsAndRelatedItemsMember" decimals="INF" unitRef="Pure"> 0.27 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_GrowPodsAndRelatedItemsMember" decimals="0" unitRef="USD"> 145000 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_GrowPodsAndRelatedItemsMember" decimals="INF" unitRef="Pure"> 0.19 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_MedtainersMember" decimals="0" unitRef="USD"> 188655 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_MedtainersMember" decimals="INF" unitRef="Pure"> 0.26 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_MedtainersMember" decimals="0" unitRef="USD"> 273961 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_MedtainersMember" decimals="INF" unitRef="Pure"> 0.36 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_LightersMember" decimals="0" unitRef="USD"> 174286 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_LightersMember" decimals="INF" unitRef="Pure"> 0.24 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_LightersMember" decimals="0" unitRef="USD"> 129600 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_LightersMember" decimals="INF" unitRef="Pure"> 0.17 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_HumidityPackInsertsMember" decimals="0" unitRef="USD"> 92884 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_HumidityPackInsertsMember" decimals="INF" unitRef="Pure"> 0.13 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_HumidityPackInsertsMember" decimals="0" unitRef="USD"> 86409 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_HumidityPackInsertsMember" decimals="INF" unitRef="Pure"> 0.11 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_PlasticLighterHoldersMember" decimals="0" unitRef="USD"> 37640 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PlasticLighterHoldersMember" decimals="INF" unitRef="Pure"> 0.05 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_PlasticLighterHoldersMember" decimals="0" unitRef="USD"> 35682 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PlasticLighterHoldersMember" decimals="INF" unitRef="Pure"> 0.05 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_PrintingMember" decimals="0" unitRef="USD"> 22450 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PrintingMember" decimals="INF" unitRef="Pure"> 0.03 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_PrintingMember" decimals="0" unitRef="USD"> 14492 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PrintingMember" decimals="INF" unitRef="Pure"> 0.02 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_ShippingChargesMember" decimals="0" unitRef="USD"> 18672 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ShippingChargesMember" decimals="INF" unitRef="Pure"> 0.03 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_ShippingChargesMember" decimals="0" unitRef="USD"> 21790 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ShippingChargesMember" decimals="INF" unitRef="Pure"> 0.03 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_JarsMember" decimals="0" unitRef="USD"> 4175 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_JarsMember" decimals="INF" unitRef="Pure"> 0.01 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_JarsMember" decimals="0" unitRef="USD"> 8900 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_JarsMember" decimals="INF" unitRef="Pure"> 0.01 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30_custom_OthersMember" decimals="0" unitRef="USD"> -1920 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OthersMember" decimals="INF" unitRef="Pure"> 0 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30_custom_OthersMember" decimals="0" unitRef="USD"> 42738 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OthersMember" decimals="INF" unitRef="Pure"> 0.06 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 739342 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AllProductsMember" decimals="INF" unitRef="Pure"> 1 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 758572 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AllProductsMember" decimals="INF" unitRef="Pure"> 1 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_LightersMember" decimals="0" unitRef="USD"> 444347 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_LightersMember" decimals="INF" unitRef="Pure"> 0.27 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_LightersMember" decimals="0" unitRef="USD"> 211859 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_LightersMember" decimals="INF" unitRef="Pure"> 0.08 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_MedtainersMember" decimals="0" unitRef="USD"> 410896 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_MedtainersMember" decimals="INF" unitRef="Pure"> 0.25 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_MedtainersMember" decimals="0" unitRef="USD"> 498745 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_MedtainersMember" decimals="INF" unitRef="Pure"> 0.19 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_GrowPodsAndRelatedItemsMember" decimals="0" unitRef="USD"> 399650 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_GrowPodsAndRelatedItemsMember" decimals="INF" unitRef="Pure"> 0.24 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_GrowPodsAndRelatedItemsMember" decimals="0" unitRef="USD"> 1470000 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_GrowPodsAndRelatedItemsMember" decimals="INF" unitRef="Pure"> 0.56 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_HumidityPackInsertsMember" decimals="0" unitRef="USD"> 173418 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_HumidityPackInsertsMember" decimals="INF" unitRef="Pure"> 0.10 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_HumidityPackInsertsMember" decimals="0" unitRef="USD"> 237663 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_HumidityPackInsertsMember" decimals="INF" unitRef="Pure"> 0.09 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_PlasticLighterHoldersMember" decimals="0" unitRef="USD"> 78198 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PlasticLighterHoldersMember" decimals="INF" unitRef="Pure"> 0.05 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_PlasticLighterHoldersMember" decimals="0" unitRef="USD"> 65368 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PlasticLighterHoldersMember" decimals="INF" unitRef="Pure"> 0.02 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_PrintingMember" decimals="0" unitRef="USD"> 55547 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PrintingMember" decimals="INF" unitRef="Pure"> 0.03 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_PrintingMember" decimals="0" unitRef="USD"> 23980 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_PrintingMember" decimals="INF" unitRef="Pure"> 0.01 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_OthersMember" decimals="0" unitRef="USD"> 49003 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OthersMember" decimals="INF" unitRef="Pure"> 0.03 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_OthersMember" decimals="0" unitRef="USD"> 67242 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OthersMember" decimals="INF" unitRef="Pure"> 0.03 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_ShippingChargesMember" decimals="0" unitRef="USD"> 42556 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ShippingChargesMember" decimals="INF" unitRef="Pure"> 0.03 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_ShippingChargesMember" decimals="0" unitRef="USD"> 39633 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ShippingChargesMember" decimals="INF" unitRef="Pure"> 0.02 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-012022-06-30_custom_JarsMember" decimals="0" unitRef="USD"> 11875 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_JarsMember" decimals="INF" unitRef="Pure"> 0.01 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30_custom_JarsMember" decimals="0" unitRef="USD"> 17040 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_JarsMember" decimals="INF" unitRef="Pure"> 0.01 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 1665490 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AllProductsMember" decimals="INF" unitRef="Pure"> 1 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 2631530 </us-gaap:Revenues>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AllProductsMember" decimals="INF" unitRef="Pure"> 1 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ScheduleOfCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeTextBlock_zpK59YkYe72h" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of customer deposits payable balance and the significant activity affecting customer deposits"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B4_zVuH1vJmZzI" style="display: none">Schedule of customer deposits</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 83%">Balance at December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--CustomerDepositsPayable_iS_c20220101__20220630_zHyBeOvveMZ6" style="width: 13%; text-align: right" title="Customer deposit at, beginning">361,230</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">New customer deposits received</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromDepositsFromCustomers_c20220101__20220630_z8bCZCNtGuV9" style="text-align: right" title="New customer deposits received">591,101</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Revenue recognized from customer deposits</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_iN_di_c20220101__20220630_zxGeH3C7vt4b" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from customer deposits">(464,995</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at June 30, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--CustomerDepositsPayable_iE_c20220101__20220630_z6xgYAZaOvcl" style="border-bottom: Black 2.5pt double; text-align: right" title="Customer deposit at ending">487,336</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
</us-gaap:ScheduleOfCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeTextBlock>
<actx:CustomerDepositsPayable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 361230 </actx:CustomerDepositsPayable>
<us-gaap:ProceedsFromDepositsFromCustomers contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 591101 </us-gaap:ProceedsFromDepositsFromCustomers>
<us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 464995 </us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
<actx:CustomerDepositsPayable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 487336 </actx:CustomerDepositsPayable>
<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2022-01-01to2022-06-30">
<p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJirwQQiICTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_864_zxmftDUpHe6h">Share-Based Payments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 718, <i>Compensation – Stock Compensation</i>, prescribes accounting and reporting standards for all share-based payment transactions. The Company follows FASB guidance related to equity-based payments, for both employees and non-employees, which requires that equity-based compensation be accounted for using a fair value method and recognized as expense in the accompanying consolidated statements of operations. Equity-based compensation expense is recognized as compensation expense over the applicable service or vesting period (see Note 7).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
<us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_840_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zrvL6JGxSfw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_860_zBcLtSIcsZC9">Fair Value Measurements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has adopted ASC Topic 820, <i>Fair Value Measurements,</i> which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, is carried on a historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of the Company’s short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features, such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 also establishes a fair-value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC Topic 820 describes three levels of inputs that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt">Level 1 - Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt">Level 2 - Quoted prices for similar assets and liabilities in active markets or inputs that are observable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt">Level 3 - Inputs that are unobservable (for example, cash flow modeling inputs based on assumptions).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.7pt"> </p>
</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
<us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_845_eus-gaap--AdvertisingCostsPolicyTextBlock_zbACY3R9wxw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_860_zktalX6oIAU4">Advertising</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising and marketing expenses are charged to operations as incurred. These expenses totaled $<span id="xdx_900_eus-gaap--MarketingAndAdvertisingExpense_c20220101__20220630_pp0p0" title="Advertising and marketing expenses">77,991</span> and $<span id="xdx_90E_eus-gaap--MarketingAndAdvertisingExpense_c20210101__20210630_pp0p0" title="Advertising and marketing expenses">32,431</span> for the six months ended June 30, 2022, and June 30, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:AdvertisingCostsPolicyTextBlock>
<us-gaap:MarketingAndAdvertisingExpense contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 77991 </us-gaap:MarketingAndAdvertisingExpense>
<us-gaap:MarketingAndAdvertisingExpense contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 32431 </us-gaap:MarketingAndAdvertisingExpense>
<us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zLkTa3fGBS94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86A_zApMNCsxsLM1">Income Taxes</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, <i>Income Taxes</i>. Under this method, income tax expense is recognized for (a) taxes payable or refundable for the current year and (b) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if, based on the weight of the available positive and negative evidence, it is more likely than not that some portion or all the deferred tax assets will not be realized. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 740-10-30 clarifies accounting for uncertainty in income taxes recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has no material uncertain tax positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zlFymcdQEH03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86B_zWYsZEqiAO0k">Concentration of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which at times may exceed the federal deposit insurance coverage of $250,000. The Company has not experienced losses on these accounts and believes that it is not exposed to significant risks on such accounts. The Company has not experienced losses on accounts receivable and the Company believes that it is not exposed to significant risks with respect to them.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:ConcentrationRiskCreditRisk>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zCzFFedOXpYb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_866_zXmZjqf9rJs6">Loss per Share</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The basic loss per share is calculated by dividing the Company’s net loss attributable to common stockholders by the weighted average number of common shares outstanding during the year. The diluted loss per share is calculated by dividing the Company’s net loss attributable to common stockholders by the diluted weighted average number of shares outstanding during the year. The potentially dilutive stock options on the Company’s common stock were not considered in the computation of diluted net loss per share as they would be anti-dilutive. <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20220101__20220630_zUCWPuBwH87k" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20210101__20210630_zfYblPmeCsa" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">No</span></span> dilutive effective as calculated for the three and six months ended June 30, 2022, and June 30, 2021, as the Company reported a net loss for each period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>
</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="Shares"> 0 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="Shares"> 0 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLtkqtP3Kh8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_866_zbFIO2eOrVic">Recent Accounting Pronouncements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows ASU 2016-02, <i>Leases (Topic 842)</i>, which requires recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and a corresponding right-of-use asset on a balance sheet for most leases, along with requirements for enhanced disclosures to enable the assessment of the amount, timing and uncertainty of cash flows arising from leasing arrangements. The Company and a related party entered into a building lease effective on September 1, 2018, which had a one-year term that expired on August 31, 2019, was renewed for a one-year term that expired on August 31, 2020, was renewed for a one-year term that expired on August 31, 2021, and has been renewed for a one-year term that expires August 31, 2022, at a monthly rent of $<span id="xdx_905_ecustom--MonthlyRent_c20220101__20220630_zfVHrpmxrR86" title="Monthly Rent">9,791</span>. On March 23, 2021, the Company and an unrelated party entered into a lease of premises in Tulsa, Oklahoma, having a monthly rental of $5,500. The lease has a one-year term that expired on March 31, 2022, and was renewed for a one-year term at the same rent. The Company is obligated to pay all taxes, insurance, operating expenses, repairs and certain maintenance costs and utilities. Because each of these leases has a term of 12 months or less and there is no assurance the Company will remain in the building locations after the leases have expired, the Company has concluded that this ASU does not apply to these leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020, FASB issued ASU 2020-06, “<i>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.</i>” For convertible instruments, FASB reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) those issued with substantial premiums for which the premiums are recorded as paid-in capital. FASB decided to amend the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. FASB observed that the application of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically similar contracts as equity. FASB also decided to improve and amend the related earnings per share guidance. The amendments in this update are effective for public business entities that meet the definition of an SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Management is currently evaluating the potential impact of this new standard.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, FASB issued ASU 2019-12, <i>Income Taxes, </i>which simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in ASC 740 related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The guidance is effective for fiscal years beginning after December 31, 2021, and interim periods within that year. The adoption did not have any material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, FASB issued ASU 2016-13 regarding ASC Topic 326, “<i>Measurement of Credit Losses on Financial Instruments</i>.” This pronouncement changes the impairment model for most financial assets and will require the use of an “expected loss” model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. Subsequently, FASB issued an amendment to clarify the implementation dates and items that fall within the scope of this pronouncement. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Management is currently evaluating the effect on the Company’s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not believe there are any other recently issued, but not yet effective, accounting standards that would have a significant impact on the Company’s financial position or results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<actx:MonthlyRent contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 9791 </actx:MonthlyRent>
<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_801_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zpFAEgJMbQu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 3 – <span id="xdx_82C_zieXOHXPWqsh">Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. At June 30, 2022, the Company had a working capital deficit of $<span id="xdx_906_ecustom--WorkingCapital_c20220630_pp0p0" title="Working capital deficit">1,165,771</span> and an accumulated deficit of $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zh9KKixSUs73" title="Accumulated deficit">6,800,851</span>. In addition, the Company has generated operating losses since its inception and has notes payable that are currently in default. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the successful execution of its operating plan, which includes increasing sales of existing products and services, introducing additional products and services, controlling operating expenses, negotiating extensions of overdue notes payable and raising either debt or equity financing. There is no assurance that the Company will be able to implement any of these measures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
<actx:WorkingCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1165771 </actx:WorkingCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> -6800851 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zzZopXR3ELLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 4 – <span id="xdx_82E_zzLOKdIIkqyb">Intangible Assets and Goodwill</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets, including patents and patent applications, a trademark and an internet domain related to Medtainer and distribution rights under a Distributorship Agreement dated August 6, 2020, are recorded at cost or estimated fair value at the date of acquisition. Goodwill relates to an Asset Purchase Agreement, amended as of June 8, 2018. The Company tested intellectual property and goodwill for impairment in preparing its financial statements for the year ended December 31, 2021, and determined that no adjustment was required. As of June 30, 2022, and December 31, 2021, there was no impairment of these assets, which are included in the tables below:  </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_z2RQlSpm1Jii" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible Assets and Goodwill (Details) - Schedule of intangible assets and goodwill"> <tr style="vertical-align: bottom; background-color: white"> <td><span id="xdx_8BD_zfEHD9VBccO5" style="display: none">Schedule of intangible assets and goodwill</span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="15" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible Assets and Goodwill at June 30, 2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Estimated Useful Life</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Amount</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributorship Agreement</span></td> <td style="width: 1%"> </td> <td id="xdx_98B_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_zWDL5Tw7PrTg" style="width: 15%" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(310,932</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 589,068</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. patents</span></td> <td> </td> <td id="xdx_989_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_zQvSK6iUx5ug" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115,853</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">319,147</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. patents</span></td> <td> </td> <td id="xdx_980_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_zb51dEbqVIC8" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16 years</span></td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(111,503</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323,497</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian patents</span></td> <td> </td> <td id="xdx_98F_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_zZ8yv9z70Xbf" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20 years</span></td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(52,563</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">207,437</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">European patents</span></td> <td> </td> <td id="xdx_98A_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_z6CsPF0ZUL5" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14 years</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,481</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,519</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molds</span></td> <td> </td> <td id="xdx_989_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_zvzf2QRlCTFi" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39,942</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,058</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td> <td> </td> <td id="xdx_989_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_zSLcaCHhdVBc" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite life</span></td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_c20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_pp0p0" style="text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_pp0p0_c20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_z6C4PeQ8Y3Of" style="text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain name</span></td> <td> </td> <td id="xdx_988_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_zUXE8RS17oE4" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite life</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98A_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_c20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_pp0p0" style="border-bottom: black 1pt solid; text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_981_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_pp0p0_c20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_zlE1jv1hSX4c" style="border-bottom: black 1pt solid; text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible totals</b></span></td> <td> </td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_988_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_c20220630_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible Assets, Gross (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2,432,000</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(639,274</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible Assets, Net (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,792,726</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></td> <td> </td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_981_eus-gaap--Goodwill_c20220630_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,020,314</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>–</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_98B_eus-gaap--Goodwill_iI_pp0p0_c20220630_zmrB55gdie2c" style="border-bottom: black 2.25pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,020,314</b></span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="15" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible Assets and Goodwill at December 31, 2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td> <td> </td> <td style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Estimated Useful Life</b></p></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying<br/> Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Amount</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GP distribution agreement</span></td> <td style="width: 1%"> </td> <td id="xdx_98B_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_zCdKXu9bIQ69" style="width: 15%" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(220,932</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">679,068</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. patents</span></td> <td> </td> <td id="xdx_981_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_zRQ8rdabJp25" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(101,597</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333,403</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. patents</span></td> <td> </td> <td id="xdx_98F_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_zmcrlmZ7SbNe" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97,781</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,219</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian patents</span></td> <td> </td> <td id="xdx_989_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_zfLbJAq2x0Bb" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20 years</span></td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(46,095</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,905</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">European patents</span></td> <td> </td> <td id="xdx_985_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_zHT7SMtb0P51" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14 years</span></td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,437</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,563</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molds</span></td> <td> </td> <td id="xdx_980_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_zeuwKhJ4Womf" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35,028</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,972</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td> <td> </td> <td id="xdx_988_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_z1PmSvAFYAfk" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite life</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_c20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_pp0p0" style="text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>–</i></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_pp0p0_c20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_zLAsO1PkdBfe" style="text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain name</span></td> <td> </td> <td id="xdx_986_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_zZq5RKleAuw8" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite life</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_986_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_c20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_pp0p0" style="border-bottom: black 1pt solid; text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>–</i></span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98B_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_pp0p0_c20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_z7Y3qUQC89Da" style="border-bottom: black 1pt solid; text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible totals</b></span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_984_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_c20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible Assets, Gross (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2,432,000</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(508,870</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible Assets, Net (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,923,130</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_982_eus-gaap--Goodwill_c20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,020,314</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_989_eus-gaap--Goodwill_iI_pp0p0_c20211231_zCpqHAPIHQE" style="border-bottom: black 2.25pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,020,314</b></span></td> <td> </td></tr> </table> <p id="xdx_8AE_zf9tXKMwBJIh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:IntangibleAssetsDisclosureTextBlock>
<us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_z2RQlSpm1Jii" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible Assets and Goodwill (Details) - Schedule of intangible assets and goodwill"> <tr style="vertical-align: bottom; background-color: white"> <td><span id="xdx_8BD_zfEHD9VBccO5" style="display: none">Schedule of intangible assets and goodwill</span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="15" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible Assets and Goodwill at June 30, 2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Estimated Useful Life</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Amount</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributorship Agreement</span></td> <td style="width: 1%"> </td> <td id="xdx_98B_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_zWDL5Tw7PrTg" style="width: 15%" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(310,932</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 589,068</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. patents</span></td> <td> </td> <td id="xdx_989_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_zQvSK6iUx5ug" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115,853</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">319,147</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. patents</span></td> <td> </td> <td id="xdx_980_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_zb51dEbqVIC8" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16 years</span></td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(111,503</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323,497</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian patents</span></td> <td> </td> <td id="xdx_98F_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_zZ8yv9z70Xbf" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20 years</span></td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(52,563</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">207,437</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">European patents</span></td> <td> </td> <td id="xdx_98A_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_z6CsPF0ZUL5" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14 years</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,481</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,519</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molds</span></td> <td> </td> <td id="xdx_989_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_zvzf2QRlCTFi" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39,942</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,058</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td> <td> </td> <td id="xdx_989_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_zSLcaCHhdVBc" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite life</span></td> <td> </td> <td> </td> <td id="xdx_98C_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_c20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_pp0p0" style="text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_pp0p0_c20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_z6C4PeQ8Y3Of" style="text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain name</span></td> <td> </td> <td id="xdx_988_ecustom--IntangibleAssetsEstimatedUsefulLives_c20220101__20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_zUXE8RS17oE4" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite life</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98A_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_c20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_pp0p0" style="border-bottom: black 1pt solid; text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_981_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_pp0p0_c20220630__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_zlE1jv1hSX4c" style="border-bottom: black 1pt solid; text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible totals</b></span></td> <td> </td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_988_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_c20220630_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible Assets, Gross (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2,432,000</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(639,274</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_985_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible Assets, Net (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,792,726</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></td> <td> </td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_981_eus-gaap--Goodwill_c20220630_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,020,314</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>–</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_98B_eus-gaap--Goodwill_iI_pp0p0_c20220630_zmrB55gdie2c" style="border-bottom: black 2.25pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,020,314</b></span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="15" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible Assets and Goodwill at December 31, 2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td> <td> </td> <td style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Estimated Useful Life</b></p></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying<br/> Value</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Amount</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GP distribution agreement</span></td> <td style="width: 1%"> </td> <td id="xdx_98B_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_zCdKXu9bIQ69" style="width: 15%" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">900,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(220,932</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DistributorshipAgreementMember_pp0p0" style="width: 13%; text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">679,068</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. patents</span></td> <td> </td> <td id="xdx_981_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_zRQ8rdabJp25" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(101,597</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333,403</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. patents</span></td> <td> </td> <td id="xdx_98F_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_zmcrlmZ7SbNe" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">435,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97,781</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--USPatents2Member_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,219</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian patents</span></td> <td> </td> <td id="xdx_989_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_zfLbJAq2x0Bb" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20 years</span></td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(46,095</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CanadianPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,905</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">European patents</span></td> <td> </td> <td id="xdx_985_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_zHT7SMtb0P51" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14 years</span></td> <td> </td> <td> </td> <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,437</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--EuropeanPatentsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,563</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molds</span></td> <td> </td> <td id="xdx_980_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_zeuwKhJ4Womf" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35,028</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--MoldsMember_pp0p0" style="text-align: right" title="Finite-Lived Intangible Assets, Net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,972</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td> <td> </td> <td id="xdx_988_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_z1PmSvAFYAfk" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite life</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_c20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_pp0p0" style="text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>–</i></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_pp0p0_c20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--TrademarkMember_zLAsO1PkdBfe" style="text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain name</span></td> <td> </td> <td id="xdx_986_ecustom--IntangibleAssetsEstimatedUsefulLives_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_zZq5RKleAuw8" title="Intangible assets estimated useful lives"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite life</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_986_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_c20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_pp0p0" style="border-bottom: black 1pt solid; text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>–</i></span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98B_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iI_pp0p0_c20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DomainNameMember_z7Y3qUQC89Da" style="border-bottom: black 1pt solid; text-align: right" title="Indefinite-Lived Intangible Assets (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible totals</b></span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_984_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_c20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible Assets, Gross (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2,432,000</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Finite-Lived Intangible Assets, Accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(508,870</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Intangible Assets, Net (Excluding Goodwill)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,923,130</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_982_eus-gaap--Goodwill_c20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,020,314</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_989_eus-gaap--Goodwill_iI_pp0p0_c20211231_zCpqHAPIHQE" style="border-bottom: black 2.25pt double; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,020,314</b></span></td> <td> </td></tr> </table>
</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2022-01-012022-06-30_custom_DistributorshipAgreementMember"> 5 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30_custom_DistributorshipAgreementMember" decimals="0" unitRef="USD"> 900000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30_custom_DistributorshipAgreementMember" decimals="0" unitRef="USD"> -310932 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30_custom_DistributorshipAgreementMember" decimals="0" unitRef="USD"> 589068 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2022-01-012022-06-30_custom_USPatentsMember"> 15 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30_custom_USPatentsMember" decimals="0" unitRef="USD"> 435000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30_custom_USPatentsMember" decimals="0" unitRef="USD"> -115853 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30_custom_USPatentsMember" decimals="0" unitRef="USD"> 319147 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2022-01-012022-06-30_custom_USPatents2Member"> 16 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30_custom_USPatents2Member" decimals="0" unitRef="USD"> 435000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30_custom_USPatents2Member" decimals="0" unitRef="USD"> -111503 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30_custom_USPatents2Member" decimals="0" unitRef="USD"> 323497 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2022-01-012022-06-30_custom_CanadianPatentsMember"> 20 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30_custom_CanadianPatentsMember" decimals="0" unitRef="USD"> 260000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30_custom_CanadianPatentsMember" decimals="0" unitRef="USD"> -52563 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30_custom_CanadianPatentsMember" decimals="0" unitRef="USD"> 207437 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2022-01-012022-06-30_custom_EuropeanPatentsMember"> 14 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30_custom_EuropeanPatentsMember" decimals="0" unitRef="USD"> 30000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30_custom_EuropeanPatentsMember" decimals="0" unitRef="USD"> -8481 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30_custom_EuropeanPatentsMember" decimals="0" unitRef="USD"> 21519 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2022-01-012022-06-30_custom_MoldsMember"> 15 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30_custom_MoldsMember" decimals="0" unitRef="USD"> 150000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30_custom_MoldsMember" decimals="0" unitRef="USD"> -39942 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30_custom_MoldsMember" decimals="0" unitRef="USD"> 110058 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2022-01-012022-06-30_custom_TrademarkMember"> Indefinite life </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2022-06-30_custom_TrademarkMember" decimals="0" unitRef="USD"> 220000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2022-06-30_custom_TrademarkMember" decimals="0" unitRef="USD"> 220000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2022-01-012022-06-30_custom_DomainNameMember"> Indefinite life </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2022-06-30_custom_DomainNameMember" decimals="0" unitRef="USD"> 2000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2022-06-30_custom_DomainNameMember" decimals="0" unitRef="USD"> 2000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 2432000 </us-gaap:IntangibleAssetsGrossExcludingGoodwill>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> -639274 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1792726 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1020314 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1020314 </us-gaap:Goodwill>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2021-01-012021-12-31_custom_DistributorshipAgreementMember"> 5 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31_custom_DistributorshipAgreementMember" decimals="0" unitRef="USD"> 900000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31_custom_DistributorshipAgreementMember" decimals="0" unitRef="USD"> -220932 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31_custom_DistributorshipAgreementMember" decimals="0" unitRef="USD"> 679068 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2021-01-012021-12-31_custom_USPatentsMember"> 15 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31_custom_USPatentsMember" decimals="0" unitRef="USD"> 435000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31_custom_USPatentsMember" decimals="0" unitRef="USD"> -101597 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31_custom_USPatentsMember" decimals="0" unitRef="USD"> 333403 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2021-01-012021-12-31_custom_USPatents2Member"> 15 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31_custom_USPatents2Member" decimals="0" unitRef="USD"> 435000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31_custom_USPatents2Member" decimals="0" unitRef="USD"> -97781 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31_custom_USPatents2Member" decimals="0" unitRef="USD"> 337219 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2021-01-012021-12-31_custom_CanadianPatentsMember"> 20 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31_custom_CanadianPatentsMember" decimals="0" unitRef="USD"> 260000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31_custom_CanadianPatentsMember" decimals="0" unitRef="USD"> -46095 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31_custom_CanadianPatentsMember" decimals="0" unitRef="USD"> 213905 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2021-01-012021-12-31_custom_EuropeanPatentsMember"> 14 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31_custom_EuropeanPatentsMember" decimals="0" unitRef="USD"> 30000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31_custom_EuropeanPatentsMember" decimals="0" unitRef="USD"> -7437 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31_custom_EuropeanPatentsMember" decimals="0" unitRef="USD"> 22563 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2021-01-012021-12-31_custom_MoldsMember"> 15 years </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31_custom_MoldsMember" decimals="0" unitRef="USD"> 150000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31_custom_MoldsMember" decimals="0" unitRef="USD"> -35028 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31_custom_MoldsMember" decimals="0" unitRef="USD"> 114972 </us-gaap:FiniteLivedIntangibleAssetsNet>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2021-01-012021-12-31_custom_TrademarkMember"> Indefinite life </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2021-12-31_custom_TrademarkMember" decimals="0" unitRef="USD"> 220000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2021-12-31_custom_TrademarkMember" decimals="0" unitRef="USD"> 220000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<actx:IntangibleAssetsEstimatedUsefulLives contextRef="From2021-01-012021-12-31_custom_DomainNameMember"> Indefinite life </actx:IntangibleAssetsEstimatedUsefulLives>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2021-12-31_custom_DomainNameMember" decimals="0" unitRef="USD"> 2000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2021-12-31_custom_DomainNameMember" decimals="0" unitRef="USD"> 2000 </us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
<us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 2432000 </us-gaap:IntangibleAssetsGrossExcludingGoodwill>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -508870 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1923130 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<us-gaap:Goodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1020314 </us-gaap:Goodwill>
<us-gaap:Goodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1020314 </us-gaap:Goodwill>
<us-gaap:DebtDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zGsZPxmkDlJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 5 – <span id="xdx_824_zRuYjhSd39di">Convertible Notes Payable and Promissory Notes Payable</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022, and December 31, 2021, the Company had outstanding the following convertible notes payable and notes payable: </p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfDebtTableTextBlock_zzuHULemle1g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable and Promissory Notes Payable (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_z6oPMPi9FOnl" style="display: none">Schedule of convertible notes payable and notes payable outstanding</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accrued</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accrued</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; font-weight: bold; text-align: left">Convertible Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt; width: 40%; text-align: left; text-indent: -5pt">July 2014 $75,000 note, convertible into common stock at $5.00 per share, 10% interest, in default (a)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_fKGEp_zPNKRAzLpsxh" style="width: 11%; text-align: right" title="Convertible Notes Payable">66,172</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_fKGEp_zPWk9YlOWRo7" style="width: 11%; text-align: right" title="Interest Payable">40,254</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_fKGEp_zp8LoIpwaaKd" style="width: 11%; text-align: right" title="Convertible Notes Payable">66,172</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_fKGEp_zVg35cb555H6" style="width: 11%; text-align: right" title="Interest Payable">36,496</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5pt; text-align: left; text-indent: -5pt">July 2014 $15,000 note, convertible into Common Stock at $5.00 per share, 10% interest, in default (a)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_fKGEp_ztrR3ehXqQs7" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Payable">15,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_fdg_____z3uVcg7pAQ6k" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">13,375</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_fKGEp_zAd99MkGuFXd" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Payable">15,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_fKGEp_zX9oaCniOeh2" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">12,625</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_c20220630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Payable">81,172</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--InterestPayableCurrentAndNoncurrent_c20220630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">53,629</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Payable">81,172</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">49,571</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; font-weight: bold; text-align: left">Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt; text-align: left; text-indent: -5pt">February 2018 $298,959 note, due February 2019, 10% interest, in default (b)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_fKGIp_zdNHS7nve1G4" style="text-align: right" title="Notes Payable">57,548</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_d0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_fKGIp_zHbN2OyEnKai" style="text-align: right" title="Interest Payable">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_fKGIp_zoQWGt2O53Q8" style="text-align: right" title="Notes Payable">162,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_fKGIp_z8zs0h60Tubi" style="text-align: right" title="Interest Payable">889</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5pt; text-align: left; text-indent: -5pt">August 2015 $75,000 note, with one-time interest charge of $75,000 (c)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_fKGMp_zhP5p1Rx1m53" style="text-align: right" title="Notes Payable">53,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_fKGMp_zXFiMqBFxSTe" style="text-align: right" title="Interest Payable">36,980</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_fKGMp_zetWyG9TPt4k" style="text-align: right" title="Notes Payable">53,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_fKGMp_zKm8wKlRTBd6" style="text-align: right" title="Interest Payable">36,980</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Related party obligation (d)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_fKGQp_z0NwV5WCuK9j" style="border-bottom: Black 1pt solid; text-align: right" title="Notes Payable">18,681</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_d0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_fKGQp_z1K2H4bR1na6" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_fKGQp_zFjBbNiexY2c" style="border-bottom: Black 1pt solid; text-align: right" title="Notes Payable">72,193</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_d0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_fKGQp_zrQQu48Jr4Kb" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayable_c20220630__us-gaap--DebtInstrumentAxis__custom--TotalNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Notes Payable">129,249</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_c20220630__us-gaap--DebtInstrumentAxis__custom--TotalNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">36,980</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--TotalNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Notes Payable">287,487</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_c20211231__us-gaap--DebtInstrumentAxis__custom--TotalNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">37,869</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebt_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term Debt">210,421</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220630_z8kP8EeYtYx3" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes Payable">90,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebt_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term Debt">368,659</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231_zJJXyE7Pa4b9" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes Payable">87,440</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span id="xdx_F0F_z1QlctMwQkka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="text-align: justify"><span id="xdx_F1A_zFexi9mfJ56a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into promissory note conversion agreements in the aggregate amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_zky6xNofLyOi" title="Debt Instrument, Face Amount">90,000</span> and made payments of $<span id="xdx_900_eus-gaap--RepaymentsOfConvertibleDebt_c20210101__20210630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_pp0p0" title="Repayments of Convertible Debt">8,828</span> on them as of June 30, 2022. These notes are convertible into shares of the Common Stock at a conversion price of $295 per share. The loans under these agreements are non-interest-bearing and have no stated maturity date; however, the Company is accruing interest at a 10% annual rate.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span id="xdx_F0A_z5ahHpOjyQxc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="text-align: justify"><span id="xdx_F11_zKMiZSEPmxMj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 22, 2018, the Company made a promissory note in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20180222__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_pp0p0" title="Debt Instrument, Face Amount">298,959</span> in favor of an unrelated party, which comprised the unpaid principal amount of $200,000 due on a prior note in favor of that party and $98,959 of accrued interest thereon. The balance of this note was $<span id="xdx_905_eus-gaap--NotesPayable_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_zndRrp0cteqa" title="Notes Payable">57,548</span> and $<span id="xdx_90E_eus-gaap--NotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_zbFWTJpA9Ic">162,274</span> at June 30, 2022, and December 31, 2021, respectively, and accrued interest was $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayablesMember_zSnHIZgc1pVe">0</span> and $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayablesMember_zT1CT7fGNsO2" title="Interest Payable">889</span>, respectively. The Note was due on February 22, 2019. The Company is negotiating an extension.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span id="xdx_F03_zmyqJ7OGPRzi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td> <td style="text-align: justify"><span id="xdx_F13_znmIGgbsAQwl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 15, 2015, the Company made a promissory note in the principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20150815__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Debt Instrument, Face Amount">150,000</span> in favor of an unrelated party. The note bears interest at 0.48% per annum, provided that the note was paid on or before its maturity date, or 2 percentage points over the Wall Street Journal Prime Rate, if not so repaid. Upon an event of default, as defined in the note, interest will be compounded daily. This note matured on August 11, 2016. During the year ended December 31, 2017, the holder of this note agreed to exchange $75,000 of principal and $663 of accrued interest on this note for 500,000 shares of common stock. This exchange was accounted for as an extinguishment of debt resulting in a loss of $683,337. In connection with this exchange, the Company agreed to pay the holder a fee of $75,000 in consideration of his waiving the default under the promissory note, as additional consideration for his agreeing to the exchange and as compensation for his foregoing the interest that would have accrued on the promissory note at the default rate but for the waiver. During the six months ended June 30, 2022, and the year ended December 31, 2021, the Company made payments of $<span id="xdx_905_eus-gaap--RepaymentsOfNotesPayable_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Repayments of Notes Payable">0</span> and $<span id="xdx_901_eus-gaap--RepaymentsOfNotesPayable_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Repayments of Notes Payable">11,227</span>, respectively, on the principal and $<span id="xdx_904_eus-gaap--InterestPaid_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities">0</span> and $<span id="xdx_900_eus-gaap--InterestPaid_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities">33,775</span>, respectively, on the interest accrued on this note. At June 30, 2022, and December 31, 2021, the balance of the note was $<span id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_z6UTixnZcbD5" title="Notes Payable">53,020</span>, respectively, and accrued interest, including the $<span id="xdx_905_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zN3mJdUQe3V8" title="Notes Payable">75,000</span> fee included therein, was $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Payable"><span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Payable">36,980</span></span>, respectively. The Company is negotiating an extension.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span id="xdx_F04_zUMFXvRvPCf9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td> <td style="text-align: justify"><span id="xdx_F12_zF3vq3TsQvv8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 15, 2020, the Company and a related party entered into a Separation Agreement, dated June 15, 2020, under which, commencing on January 1, 2021, the Company agreed to repay $145,844 that the Company owed him in 24 monthly payments of $6,093, including interest at the Applicable Federal Rate. During the six months ended June 30, 2022, and the year ended December 31, 2021, the Company made payments of $<span id="xdx_90A_eus-gaap--RepaymentsOfNotesPayable_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Repayments of Notes Payable">53,513</span> and $<span id="xdx_906_eus-gaap--RepaymentsOfNotesPayable_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Repayments of Notes Payable">90,000</span>, respectively. At June 30, 2022, and December 31, 2021, the balance of the note was $<span id="xdx_908_eus-gaap--NotesPayable_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Notes Payable">18,681</span> and $<span id="xdx_90F_eus-gaap--NotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Notes Payable">72,193</span>, respectively.</span></td></tr> </table> <p id="xdx_8A0_z4rFGw2snTN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:DebtDisclosureTextBlock>
<us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfDebtTableTextBlock_zzuHULemle1g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable and Promissory Notes Payable (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_z6oPMPi9FOnl" style="display: none">Schedule of convertible notes payable and notes payable outstanding</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accrued</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accrued</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Principal</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Interest</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; font-weight: bold; text-align: left">Convertible Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt; width: 40%; text-align: left; text-indent: -5pt">July 2014 $75,000 note, convertible into common stock at $5.00 per share, 10% interest, in default (a)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_fKGEp_zPNKRAzLpsxh" style="width: 11%; text-align: right" title="Convertible Notes Payable">66,172</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_fKGEp_zPWk9YlOWRo7" style="width: 11%; text-align: right" title="Interest Payable">40,254</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_fKGEp_zp8LoIpwaaKd" style="width: 11%; text-align: right" title="Convertible Notes Payable">66,172</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_fKGEp_zVg35cb555H6" style="width: 11%; text-align: right" title="Interest Payable">36,496</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5pt; text-align: left; text-indent: -5pt">July 2014 $15,000 note, convertible into Common Stock at $5.00 per share, 10% interest, in default (a)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_fKGEp_ztrR3ehXqQs7" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Payable">15,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_fdg_____z3uVcg7pAQ6k" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">13,375</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_fKGEp_zAd99MkGuFXd" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Payable">15,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_fKGEp_zX9oaCniOeh2" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">12,625</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_c20220630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Payable">81,172</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--InterestPayableCurrentAndNoncurrent_c20220630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">53,629</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible Notes Payable">81,172</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_c20211231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">49,571</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; font-weight: bold; text-align: left">Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5pt; text-align: left; text-indent: -5pt">February 2018 $298,959 note, due February 2019, 10% interest, in default (b)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_fKGIp_zdNHS7nve1G4" style="text-align: right" title="Notes Payable">57,548</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_d0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_fKGIp_zHbN2OyEnKai" style="text-align: right" title="Interest Payable">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_fKGIp_zoQWGt2O53Q8" style="text-align: right" title="Notes Payable">162,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_fKGIp_z8zs0h60Tubi" style="text-align: right" title="Interest Payable">889</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5pt; text-align: left; text-indent: -5pt">August 2015 $75,000 note, with one-time interest charge of $75,000 (c)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_fKGMp_zhP5p1Rx1m53" style="text-align: right" title="Notes Payable">53,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_fKGMp_zXFiMqBFxSTe" style="text-align: right" title="Interest Payable">36,980</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_fKGMp_zetWyG9TPt4k" style="text-align: right" title="Notes Payable">53,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_fKGMp_zKm8wKlRTBd6" style="text-align: right" title="Interest Payable">36,980</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Related party obligation (d)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_fKGQp_z0NwV5WCuK9j" style="border-bottom: Black 1pt solid; text-align: right" title="Notes Payable">18,681</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_d0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_fKGQp_z1K2H4bR1na6" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_fKGQp_zFjBbNiexY2c" style="border-bottom: Black 1pt solid; text-align: right" title="Notes Payable">72,193</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_d0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_fKGQp_zrQQu48Jr4Kb" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayable_c20220630__us-gaap--DebtInstrumentAxis__custom--TotalNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Notes Payable">129,249</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--InterestPayableCurrentAndNoncurrent_c20220630__us-gaap--DebtInstrumentAxis__custom--TotalNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">36,980</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--TotalNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Notes Payable">287,487</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_c20211231__us-gaap--DebtInstrumentAxis__custom--TotalNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest Payable">37,869</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebt_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term Debt">210,421</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220630_z8kP8EeYtYx3" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes Payable">90,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebt_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term Debt">368,659</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231_zJJXyE7Pa4b9" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes Payable">87,440</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span id="xdx_F0F_z1QlctMwQkka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="text-align: justify"><span id="xdx_F1A_zFexi9mfJ56a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into promissory note conversion agreements in the aggregate amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_zky6xNofLyOi" title="Debt Instrument, Face Amount">90,000</span> and made payments of $<span id="xdx_900_eus-gaap--RepaymentsOfConvertibleDebt_c20210101__20210630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_pp0p0" title="Repayments of Convertible Debt">8,828</span> on them as of June 30, 2022. These notes are convertible into shares of the Common Stock at a conversion price of $295 per share. The loans under these agreements are non-interest-bearing and have no stated maturity date; however, the Company is accruing interest at a 10% annual rate.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span id="xdx_F0A_z5ahHpOjyQxc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="text-align: justify"><span id="xdx_F11_zKMiZSEPmxMj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 22, 2018, the Company made a promissory note in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20180222__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_pp0p0" title="Debt Instrument, Face Amount">298,959</span> in favor of an unrelated party, which comprised the unpaid principal amount of $200,000 due on a prior note in favor of that party and $98,959 of accrued interest thereon. The balance of this note was $<span id="xdx_905_eus-gaap--NotesPayable_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_zndRrp0cteqa" title="Notes Payable">57,548</span> and $<span id="xdx_90E_eus-gaap--NotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_zbFWTJpA9Ic">162,274</span> at June 30, 2022, and December 31, 2021, respectively, and accrued interest was $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayablesMember_zSnHIZgc1pVe">0</span> and $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayablesMember_zT1CT7fGNsO2" title="Interest Payable">889</span>, respectively. The Note was due on February 22, 2019. The Company is negotiating an extension.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span id="xdx_F03_zmyqJ7OGPRzi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td> <td style="text-align: justify"><span id="xdx_F13_znmIGgbsAQwl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 15, 2015, the Company made a promissory note in the principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20150815__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Debt Instrument, Face Amount">150,000</span> in favor of an unrelated party. The note bears interest at 0.48% per annum, provided that the note was paid on or before its maturity date, or 2 percentage points over the Wall Street Journal Prime Rate, if not so repaid. Upon an event of default, as defined in the note, interest will be compounded daily. This note matured on August 11, 2016. During the year ended December 31, 2017, the holder of this note agreed to exchange $75,000 of principal and $663 of accrued interest on this note for 500,000 shares of common stock. This exchange was accounted for as an extinguishment of debt resulting in a loss of $683,337. In connection with this exchange, the Company agreed to pay the holder a fee of $75,000 in consideration of his waiving the default under the promissory note, as additional consideration for his agreeing to the exchange and as compensation for his foregoing the interest that would have accrued on the promissory note at the default rate but for the waiver. During the six months ended June 30, 2022, and the year ended December 31, 2021, the Company made payments of $<span id="xdx_905_eus-gaap--RepaymentsOfNotesPayable_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Repayments of Notes Payable">0</span> and $<span id="xdx_901_eus-gaap--RepaymentsOfNotesPayable_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Repayments of Notes Payable">11,227</span>, respectively, on the principal and $<span id="xdx_904_eus-gaap--InterestPaid_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities">0</span> and $<span id="xdx_900_eus-gaap--InterestPaid_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities">33,775</span>, respectively, on the interest accrued on this note. At June 30, 2022, and December 31, 2021, the balance of the note was $<span id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_z6UTixnZcbD5" title="Notes Payable">53,020</span>, respectively, and accrued interest, including the $<span id="xdx_905_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zN3mJdUQe3V8" title="Notes Payable">75,000</span> fee included therein, was $<span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Payable"><span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Payable">36,980</span></span>, respectively. The Company is negotiating an extension.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span id="xdx_F04_zUMFXvRvPCf9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td> <td style="text-align: justify"><span id="xdx_F12_zF3vq3TsQvv8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 15, 2020, the Company and a related party entered into a Separation Agreement, dated June 15, 2020, under which, commencing on January 1, 2021, the Company agreed to repay $145,844 that the Company owed him in 24 monthly payments of $6,093, including interest at the Applicable Federal Rate. During the six months ended June 30, 2022, and the year ended December 31, 2021, the Company made payments of $<span id="xdx_90A_eus-gaap--RepaymentsOfNotesPayable_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Repayments of Notes Payable">53,513</span> and $<span id="xdx_906_eus-gaap--RepaymentsOfNotesPayable_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Repayments of Notes Payable">90,000</span>, respectively. At June 30, 2022, and December 31, 2021, the balance of the note was $<span id="xdx_908_eus-gaap--NotesPayable_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Notes Payable">18,681</span> and $<span id="xdx_90F_eus-gaap--NotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Notes Payable">72,193</span>, respectively.</span></td></tr> </table>
</us-gaap:ScheduleOfDebtTableTextBlock>
<us-gaap:ConvertibleNotesPayable contextRef="AsOf2022-06-30_custom_ConvertibleNotesPayable1Member" decimals="0" id="Fact000904" unitRef="USD"> 66172 </us-gaap:ConvertibleNotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_custom_ConvertibleNotesPayable1Member" decimals="0" id="Fact000906" unitRef="USD"> 40254 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:ConvertibleNotesPayable contextRef="AsOf2021-12-31_custom_ConvertibleNotesPayable1Member" decimals="0" id="Fact000908" unitRef="USD"> 66172 </us-gaap:ConvertibleNotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_custom_ConvertibleNotesPayable1Member" decimals="0" id="Fact000910" unitRef="USD"> 36496 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:ConvertibleNotesPayable contextRef="AsOf2022-06-30_custom_ConvertibleNotesPayable2Member" decimals="0" id="Fact000912" unitRef="USD"> 15000 </us-gaap:ConvertibleNotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_custom_ConvertibleNotesPayable2Member" decimals="0" unitRef="USD"> 13375 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:ConvertibleNotesPayable contextRef="AsOf2021-12-31_custom_ConvertibleNotesPayable2Member" decimals="0" id="Fact000916" unitRef="USD"> 15000 </us-gaap:ConvertibleNotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_custom_ConvertibleNotesPayable2Member" decimals="0" id="Fact000918" unitRef="USD"> 12625 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:ConvertibleNotesPayable contextRef="AsOf2022-06-30_us-gaap_ConvertibleNotesPayableMember" decimals="0" unitRef="USD"> 81172 </us-gaap:ConvertibleNotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_us-gaap_ConvertibleNotesPayableMember" decimals="0" unitRef="USD"> 53629 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:ConvertibleNotesPayable contextRef="AsOf2021-12-31_us-gaap_ConvertibleNotesPayableMember" decimals="0" unitRef="USD"> 81172 </us-gaap:ConvertibleNotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_us-gaap_ConvertibleNotesPayableMember" decimals="0" unitRef="USD"> 49571 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:NotesPayable contextRef="AsOf2022-06-30_custom_NotesPayable1Member" decimals="0" id="Fact000928" unitRef="USD"> 57548 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_custom_NotesPayable1Member" decimals="0" id="Fact000930" unitRef="USD"> 0 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:NotesPayable contextRef="AsOf2021-12-31_custom_NotesPayable1Member" decimals="0" id="Fact000932" unitRef="USD"> 162274 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_custom_NotesPayable1Member" decimals="0" id="Fact000934" unitRef="USD"> 889 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:NotesPayable contextRef="AsOf2022-06-30_custom_NotesPayable2Member" decimals="0" id="Fact000936" unitRef="USD"> 53020 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_custom_NotesPayable2Member" decimals="0" id="Fact000938" unitRef="USD"> 36980 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:NotesPayable contextRef="AsOf2021-12-31_custom_NotesPayable2Member" decimals="0" id="Fact000940" unitRef="USD"> 53020 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_custom_NotesPayable2Member" decimals="0" id="Fact000942" unitRef="USD"> 36980 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:NotesPayable contextRef="AsOf2022-06-30_custom_NotesPayable3Member" decimals="0" id="Fact000944" unitRef="USD"> 18681 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_custom_NotesPayable3Member" decimals="0" id="Fact000946" unitRef="USD"> 0 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:NotesPayable contextRef="AsOf2021-12-31_custom_NotesPayable3Member" decimals="0" id="Fact000948" unitRef="USD"> 72193 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_custom_NotesPayable3Member" decimals="0" id="Fact000950" unitRef="USD"> 0 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:NotesPayable contextRef="AsOf2022-06-30_custom_TotalNotesPayableMember" decimals="0" unitRef="USD"> 129249 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_custom_TotalNotesPayableMember" decimals="0" unitRef="USD"> 36980 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:NotesPayable contextRef="AsOf2021-12-31_custom_TotalNotesPayableMember" decimals="0" unitRef="USD"> 287487 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_custom_TotalNotesPayableMember" decimals="0" unitRef="USD"> 37869 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:LongTermDebt contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 210421 </us-gaap:LongTermDebt>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 90609 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:LongTermDebt contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 368659 </us-gaap:LongTermDebt>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 87440 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2022-06-30_custom_ConvertibleNotesPayable1Member" decimals="0" unitRef="USD"> 90000 </us-gaap:DebtInstrumentFaceAmount>
<us-gaap:RepaymentsOfConvertibleDebt contextRef="From2021-01-012021-06-30_custom_ConvertibleNotesPayable1Member" decimals="0" unitRef="USD"> 8828 </us-gaap:RepaymentsOfConvertibleDebt>
<us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2018-02-22_custom_ConvertibleNotesPayable2Member" decimals="0" unitRef="USD"> 298959 </us-gaap:DebtInstrumentFaceAmount>
<us-gaap:NotesPayable contextRef="AsOf2022-06-30_custom_NotesPayable1Member" decimals="0" unitRef="USD"> 57548 </us-gaap:NotesPayable>
<us-gaap:NotesPayable contextRef="AsOf2021-12-31_custom_NotesPayable1Member" decimals="0" unitRef="USD"> 162274 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_custom_ConvertibleNotesPayablesMember" decimals="0" unitRef="USD"> 0 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_custom_ConvertibleNotesPayablesMember" decimals="0" unitRef="USD"> 889 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-08-15_custom_NotesPayable2Member" decimals="0" unitRef="USD"> 150000 </us-gaap:DebtInstrumentFaceAmount>
<us-gaap:RepaymentsOfNotesPayable contextRef="From2022-01-012022-06-30_custom_NotesPayable2Member" decimals="0" unitRef="USD"> 0 </us-gaap:RepaymentsOfNotesPayable>
<us-gaap:RepaymentsOfNotesPayable contextRef="From2021-01-012021-12-31_custom_NotesPayable2Member" decimals="0" unitRef="USD"> 11227 </us-gaap:RepaymentsOfNotesPayable>
<us-gaap:InterestPaid contextRef="From2022-01-012022-06-30_custom_NotesPayable2Member" decimals="0" unitRef="USD"> 0 </us-gaap:InterestPaid>
<us-gaap:InterestPaid contextRef="From2021-01-012021-12-31_custom_NotesPayable2Member" decimals="0" unitRef="USD"> 33775 </us-gaap:InterestPaid>
<us-gaap:NotesPayable contextRef="AsOf2022-06-30_custom_NotesPayableMember" decimals="0" unitRef="USD"> 53020 </us-gaap:NotesPayable>
<us-gaap:NotesPayable contextRef="AsOf2021-12-31_custom_NotesPayableMember" decimals="0" unitRef="USD"> 75000 </us-gaap:NotesPayable>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30_custom_NotesPayable2Member" decimals="0" unitRef="USD"> 36980 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31_custom_NotesPayable2Member" decimals="0" unitRef="USD"> 36980 </us-gaap:InterestPayableCurrentAndNoncurrent>
<us-gaap:RepaymentsOfNotesPayable contextRef="From2022-01-012022-06-30_custom_NotesPayable3Member" decimals="0" unitRef="USD"> 53513 </us-gaap:RepaymentsOfNotesPayable>
<us-gaap:RepaymentsOfNotesPayable contextRef="From2021-01-012021-12-31_custom_NotesPayable3Member" decimals="0" unitRef="USD"> 90000 </us-gaap:RepaymentsOfNotesPayable>
<us-gaap:NotesPayable contextRef="AsOf2022-06-30_custom_NotesPayable3Member" decimals="0" unitRef="USD"> 18681 </us-gaap:NotesPayable>
<us-gaap:NotesPayable contextRef="AsOf2021-12-31_custom_NotesPayable3Member" decimals="0" unitRef="USD"> 72193 </us-gaap:NotesPayable>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zSAvgjxK4Oq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6 – <span id="xdx_82C_z00ErksPN3v4">Stockholders’ Equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 8, 2020, the Company combined the outstanding shares of its common stock on the basis of 1 share of common stock for every 59 shares of common stock. The effects of this combination have been retroactively applied to all periods presented in the unaudited consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 30, 2020, the Company filed articles of amendment with the Secretary of State of the State of Florida, pursuant to which, a series of 1,000,000 of its 10,000,000 authorized shares of preferred stock was designated, which series is named Series A Convertible Preferred Stock (“Series A Preferred”). Each share of Series A Preferred is convertible into 0.3051 shares of Common Stock, has the dividend and distribution rights and redemption rights of the shares of Common Stock into which it is convertible, is not redeemable and has voting power equal to the combined voting power of all other of classes and series of the Company’s capital stock. On June 24, 2020, the Company issued all of the shares of this series to a related party in exchange for 305,085 shares of Common Stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 9, 2020, the Company issued 50,000,000 shares of Common Stock to the shareholders of ACT in exchange for their shares in ACT pursuant to the Exchange Agreement. See Note 1. As a result, ACT became the wholly owned subsidiary of the Company and the Company acquired the Distributorship Agreement, which has been valued as an intangible asset at $900,000 (see Note 4) and $86,293 in cash. Under the Distributorship Agreement, ACT has the exclusive right to purchase GrowPods and related products at prices to be agreed to from time to time and to sell and distribute them within the United States and its territories for an initial term that will expire on December 31, 2025. ACT may renew the Distributorship Agreement indefinitely as long as it purchases the lesser of (i) 100 GrowPods or (ii) GP’s total output of GrowPods in the last calendar year of any term. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 1, 2021, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20210102__srt--CounterpartyNameAxis__srt--DirectorMember_zPv4vjSq21S2" title="Stock Issued During Period, Shares, Issued for Services">120,000</span> shares of Common Stock to one of the Company’s directors as compensation pursuant to a Director Agreement between the Company and him, dated as of that date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2022, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220630__srt--CounterpartyNameAxis__custom--FourUnrelatedPersonsMember_pdd" title="Stock Issued During Period, Shares, New Issues">280,001</span> shares of Common Stock to four individuals. The aggregate purchase price of these shares was $<span id="xdx_90B_ecustom--AggregatePurchasePrice_pp0p0_c20220101__20220630__srt--CounterpartyNameAxis__custom--FourUnrelatedPersonsMember_zmvNC2D1HzK6" title="Aggregate purchase price">210,000</span>. During the year ended December 31, 2021, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20211231__srt--CounterpartyNameAxis__custom--EightUnrelatedPersonsMember_pdd" title="Stock Issued During Period, Shares, New Issues">485,000</span> shares of Common Stock to eight individuals. The aggregate purchase price of these shares was $<span id="xdx_909_ecustom--AggregatePurchasePrice_pp0p0_c20210101__20211231__srt--CounterpartyNameAxis__custom--EightUnrelatedPersonsMember_zvN5obdVACof" title="Aggregate purchase price">615,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2021-01-012021-01-02_srt_DirectorMember" decimals="INF" unitRef="Shares"> 120000 </us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2022-01-012022-06-30_custom_FourUnrelatedPersonsMember" decimals="INF" unitRef="Shares"> 280001 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<actx:AggregatePurchasePrice contextRef="From2022-01-012022-06-30_custom_FourUnrelatedPersonsMember" decimals="0" unitRef="USD"> 210000 </actx:AggregatePurchasePrice>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2021-01-012021-12-31_custom_EightUnrelatedPersonsMember" decimals="INF" unitRef="Shares"> 485000 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<actx:AggregatePurchasePrice contextRef="From2021-01-012021-12-31_custom_EightUnrelatedPersonsMember" decimals="0" unitRef="USD"> 615000 </actx:AggregatePurchasePrice>
<us-gaap:CompensationRelatedCostsGeneralTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_80C_eus-gaap--CompensationRelatedCostsGeneralTextBlock_zUNCt0LmhA18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 7 – <span id="xdx_82F_zzILIiVk4Z12">Share-Based Compensation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s 2018 Incentive Award Plan (the “2018 Plan”) became effective on December 1, 2018, under which the Company may issue up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20181231__us-gaap--PlanNameAxis__custom--Plan2018Member_pdd" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized">33,898</span> shares of common stock as incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, and other forms of compensation to employees, directors and consultants. In addition, the 2018 Plan provides for the grant of performance cash awards to employees, directors and consultants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 1, 2018, 22,882 shares of common stock were awarded to employees in the form of restricted shares and 5,678 shares of common stock were awarded to consultants as compensation. The fair value of these shares on the grant date was $0.59 per share. As of December 31, 2020, all of these shares had vested. The following table shows vesting for financial reporting purposes under GAAP of the shares issued under the 2018 Plan: </p> <table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zIBc3vlp96bi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-Based Compensation (Details) - Schedule of share based compensation"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zsAEnVL7FvEc" style="display: none">Schedule of share based compensation</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares of Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Vesting Dates</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Employees</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Consultants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">December 31, 2018</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20181231__srt--CounterpartyNameAxis__custom--EmployeesMember_zS0f9TZNpyE9" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20181231__srt--CounterpartyNameAxis__custom--ConsultantsMember_pdd" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">3,136</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>January 1, 2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20190102__srt--CounterpartyNameAxis__custom--EmployeesMember_ztVbJvzQEA9f" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">12,712</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20190102__srt--CounterpartyNameAxis__custom--ConsultantsMember_ztMhX9YmsqHc" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>March 31, 2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20190331__srt--CounterpartyNameAxis__custom--EmployeesMember_zHyKQ3m4lsq6" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20190331__srt--CounterpartyNameAxis__custom--ConsultantsMember_zN0lOT20or3h" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">2,542</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>June 30, 2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20190630__srt--CounterpartyNameAxis__custom--EmployeesMember_zoit3Q44odNi" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">5,085</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20190630__srt--CounterpartyNameAxis__custom--ConsultantsMember_z46bLBWbYSVl" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">June 30, 2020</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20200630__srt--CounterpartyNameAxis__custom--EmployeesMember_z8MuJp9Ypz4b" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">5,085</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20200630__srt--CounterpartyNameAxis__custom--ConsultantsMember_zriIF3cBaSz1" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total vested at June 30, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20220630__srt--CounterpartyNameAxis__custom--EmployeesMember_zycNOQOwrlDg" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">22,882</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20220630__srt--CounterpartyNameAxis__custom--ConsultantsMember_z0tR5xSflQQ5" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">5,678</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company made no awards in any other form during the six months ended June 30, 2022, and June 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expensed $<span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__custom--Plan2018Member_pp0p0" title="Share-based Payment Arrangement, Noncash Expense"><span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__custom--Plan2018Member_pp0p0" title="Share-based Payment Arrangement, Noncash Expense">0</span></span> for share-based compensation under the 2018 Plan in the six months ended June 30, 2022, and June 30, 2021, respectively, for its employees and consultants in the accompanying consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 1, 2021, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20210102__srt--CounterpartyNameAxis__srt--DirectorMember_pdd" title="Stock Issued During Period, Shares, Issued for Services">120,000</span> shares of Common Stock to one of its directors, as compensation pursuant to a Director Agreement, dated as of that date and, in the six months ended June 30, 2021, the Company expensed $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210101__20210102__srt--CounterpartyNameAxis__srt--DirectorMember_pp0p0" title="Stock Issued During Period, Value, Issued for Services">270,000</span> for share-based compensation in respect of these shares (see Note 6), based on their fair market value of $2.25 per share on their date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>
</us-gaap:CompensationRelatedCostsGeneralTextBlock>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2018-12-31_custom_Plan2018Member" decimals="INF" unitRef="Shares"> 33898 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
<us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_zIBc3vlp96bi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-Based Compensation (Details) - Schedule of share based compensation"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zsAEnVL7FvEc" style="display: none">Schedule of share based compensation</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares of Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Vesting Dates</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Employees</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Consultants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">December 31, 2018</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20181231__srt--CounterpartyNameAxis__custom--EmployeesMember_zS0f9TZNpyE9" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20181231__srt--CounterpartyNameAxis__custom--ConsultantsMember_pdd" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">3,136</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>January 1, 2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20190102__srt--CounterpartyNameAxis__custom--EmployeesMember_ztVbJvzQEA9f" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">12,712</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20190102__srt--CounterpartyNameAxis__custom--ConsultantsMember_ztMhX9YmsqHc" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>March 31, 2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20190331__srt--CounterpartyNameAxis__custom--EmployeesMember_zHyKQ3m4lsq6" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20190331__srt--CounterpartyNameAxis__custom--ConsultantsMember_zN0lOT20or3h" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">2,542</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>June 30, 2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20190630__srt--CounterpartyNameAxis__custom--EmployeesMember_zoit3Q44odNi" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">5,085</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20190630__srt--CounterpartyNameAxis__custom--ConsultantsMember_z46bLBWbYSVl" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">June 30, 2020</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20200630__srt--CounterpartyNameAxis__custom--EmployeesMember_z8MuJp9Ypz4b" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">5,085</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0_c20181201__20200630__srt--CounterpartyNameAxis__custom--ConsultantsMember_zriIF3cBaSz1" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total vested at June 30, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20220630__srt--CounterpartyNameAxis__custom--EmployeesMember_zycNOQOwrlDg" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">22,882</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20181201__20220630__srt--CounterpartyNameAxis__custom--ConsultantsMember_z0tR5xSflQQ5" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period">5,678</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
</us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012018-12-31_custom_EmployeesMember" decimals="INF" unitRef="Shares"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012018-12-31_custom_ConsultantsMember" decimals="INF" unitRef="Shares"> 3136 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012019-01-02_custom_EmployeesMember" decimals="INF" unitRef="Shares"> 12712 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012019-01-02_custom_ConsultantsMember" decimals="INF" unitRef="Shares"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012019-03-31_custom_EmployeesMember" decimals="INF" unitRef="Shares"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012019-03-31_custom_ConsultantsMember" decimals="INF" unitRef="Shares"> 2542 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012019-06-30_custom_EmployeesMember" decimals="INF" unitRef="Shares"> 5085 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012019-06-30_custom_ConsultantsMember" decimals="INF" unitRef="Shares"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012020-06-30_custom_EmployeesMember" decimals="INF" unitRef="Shares"> 5085 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012020-06-30_custom_ConsultantsMember" decimals="INF" unitRef="Shares"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012022-06-30_custom_EmployeesMember" decimals="INF" unitRef="Shares"> 22882 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2018-12-012022-06-30_custom_ConsultantsMember" decimals="INF" unitRef="Shares"> 5678 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensation contextRef="From2022-01-012022-06-30_custom_Plan2018Member" decimals="0" unitRef="USD"> 0 </us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="From2021-01-012021-06-30_custom_Plan2018Member" decimals="0" unitRef="USD"> 0 </us-gaap:ShareBasedCompensation>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2021-01-012021-01-02_srt_DirectorMember" decimals="INF" unitRef="Shares"> 120000 </us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-01-012021-01-02_srt_DirectorMember" decimals="0" unitRef="USD"> 270000 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zURHCGXRTEq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 8 – <span id="xdx_828_zlLyuw9SnzGh">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the Company had approximately $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20211231__us-gaap--IncomeTaxAuthorityAxis__custom--FederalMember_pp0p0" title="Operating Loss Carryforwards">2,351,000</span> and $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_c20211231__us-gaap--IncomeTaxAuthorityAxis__custom--StateMember_pp0p0" title="Operating Loss Carryforwards">1,649,000</span> of net operating loss carryforwards (“NOLs”) available to reduce future Federal and California, respectively, taxable income, which will begin to expire in 2031. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against all the deferred tax assets for every period because it is more likely than not that the deferred tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “2017 Tax Act”) was enacted, making significant changes to the Internal Revenue Code. Changes include a federal corporate tax rate decrease from 35% to 21% for tax years beginning after December 31, 2017, the transition of U.S. international taxation from a worldwide tax system to a territorial system and a one-time transition tax on the mandatory deemed repatriation of foreign earnings. The Company has estimated its provision for income taxes in accordance with the 2017 Tax Act and the guidance available and, based thereon, has determined that the 2017 Tax Act does not change the determination that it is more likely than not that the deferred tax assets will not be realized. Accordingly, the Company has kept the full valuation allowance. As a result, the Company recorded $1,600 and $2,700, respectively, for minimum State franchise fees in general and administrative expenses during the six months ended June 30, 2022, and June 30, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:IncomeTaxDisclosureTextBlock>
<us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-12-31_custom_FederalMember" decimals="0" unitRef="USD"> 2351000 </us-gaap:OperatingLossCarryforwards>
<us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-12-31_custom_StateMember" decimals="0" unitRef="USD"> 1649000 </us-gaap:OperatingLossCarryforwards>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zL8wxRJ1IeW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 9 – <span id="xdx_823_zVGupnJ9cQ5g">Related-Party Transactions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Loans</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has received loans from its officers and directors from time to time since its inception. During the six months ended June 30, 2022, the Company received $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20220101__20220630_pp0p0" title="Proceeds from Related Party Debt">163,351</span> in loans from one of its officers and directors and repaid $<span id="xdx_903_eus-gaap--RepaymentsOfRelatedPartyDebt_c20220101__20220630_pp0p0" title="Repayments of Related Party Debt">96,866</span> of these loans. During the six months ended June 30, 2021, the Company received $<span id="xdx_908_eus-gaap--ProceedsFromRelatedPartyDebt_c20210101__20210630_pp0p0" title="Proceeds from Related Party Debt">1,350</span> and repaid $<span id="xdx_90D_eus-gaap--RepaymentsOfRelatedPartyDebt_c20210101__20210630_pp0p0" title="Repayments of Related Party Debt">93,474</span> of these loans. The balance of these loans at June 30, 2022, and December 31, 2021, was $<span id="xdx_90F_ecustom--LoansReceived_iI_c20220630__us-gaap--AssetsSoldUnderAgreementsToRepurchaseAxis__us-gaap--LoansMember_z0dKmIz0Nmxb" title="Loans received">386,896</span> and $<span id="xdx_90D_ecustom--LoansReceived_iI_c20211231__us-gaap--AssetsSoldUnderAgreementsToRepurchaseAxis__us-gaap--LoansMember_zZNiZSytztll" title="Loans received">320,411</span>, respectively. All of these loans are non-interest-bearing and have no set maturity date. The Company expects to repay these loans when cash flows become available.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Contracts</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company makes building lease payments and purchases products for resale from entities owned by a related party, who is also one of its executive officers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payments made to related parties for the six months ended June 30, 2022, and June 30, 2021, were as follows: </p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zIJVlVkstFI" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related-Party Transactions (Details) - Schedule of related party transactions"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zLLTNhLfA6Ai" style="display: none">Schedule of related party transactions</span></td><td> </td> <td colspan="2" id="xdx_49C_20220101__20220630_zXRGjX2Is4hj" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_491_20210101__20210630_zECvJdS8F24h" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--CostsAndExpensesRelatedParty_hus-gaap--RelatedPartyTransactionAxis__custom--BuildingLeasePaymentsMember_zQdUNUmC6cYl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Building lease payments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">56,394</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">54,042</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--CostsAndExpensesRelatedParty_hus-gaap--RelatedPartyTransactionAxis__custom--PurchaseOfProductsForResaleMember_zgw0iWLHhHJi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Purchase of products for resale</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">270,659</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">180,121</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CostsAndExpensesRelatedParty_zuh2vWfHrkn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">327,053</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,163</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Director Compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 1, 2021, the Company issued 120,000 shares of Common Stock to one of its directors as compensation pursuant to a Director Agreement, dated as of that date. (See Note 7.)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 163351 </us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 96866 </us-gaap:RepaymentsOfRelatedPartyDebt>
<us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 1350 </us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 93474 </us-gaap:RepaymentsOfRelatedPartyDebt>
<actx:LoansReceived contextRef="AsOf2022-06-30_us-gaap_LoansMember" decimals="0" unitRef="USD"> 386896 </actx:LoansReceived>
<actx:LoansReceived contextRef="AsOf2021-12-31_us-gaap_LoansMember" decimals="0" unitRef="USD"> 320411 </actx:LoansReceived>
<us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zIJVlVkstFI" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related-Party Transactions (Details) - Schedule of related party transactions"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zLLTNhLfA6Ai" style="display: none">Schedule of related party transactions</span></td><td> </td> <td colspan="2" id="xdx_49C_20220101__20220630_zXRGjX2Is4hj" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_491_20210101__20210630_zECvJdS8F24h" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--CostsAndExpensesRelatedParty_hus-gaap--RelatedPartyTransactionAxis__custom--BuildingLeasePaymentsMember_zQdUNUmC6cYl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Building lease payments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">56,394</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">54,042</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--CostsAndExpensesRelatedParty_hus-gaap--RelatedPartyTransactionAxis__custom--PurchaseOfProductsForResaleMember_zgw0iWLHhHJi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Purchase of products for resale</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">270,659</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">180,121</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CostsAndExpensesRelatedParty_zuh2vWfHrkn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">327,053</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,163</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
<us-gaap:CostsAndExpensesRelatedParty contextRef="From2022-01-012022-06-30_custom_BuildingLeasePaymentsMember" decimals="0" unitRef="USD"> 56394 </us-gaap:CostsAndExpensesRelatedParty>
<us-gaap:CostsAndExpensesRelatedParty contextRef="From2021-01-012021-06-30_custom_BuildingLeasePaymentsMember" decimals="0" unitRef="USD"> 54042 </us-gaap:CostsAndExpensesRelatedParty>
<us-gaap:CostsAndExpensesRelatedParty contextRef="From2022-01-012022-06-30_custom_PurchaseOfProductsForResaleMember" decimals="0" unitRef="USD"> 270659 </us-gaap:CostsAndExpensesRelatedParty>
<us-gaap:CostsAndExpensesRelatedParty contextRef="From2021-01-012021-06-30_custom_PurchaseOfProductsForResaleMember" decimals="0" unitRef="USD"> 180121 </us-gaap:CostsAndExpensesRelatedParty>
<us-gaap:CostsAndExpensesRelatedParty contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 327053 </us-gaap:CostsAndExpensesRelatedParty>
<us-gaap:CostsAndExpensesRelatedParty contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 234163 </us-gaap:CostsAndExpensesRelatedParty>
<us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_z7baVfgI5kXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 10 – <span id="xdx_82C_zx5orTIBdcki">Concentrations</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three months ended June 30, 2022, two of the Company’s customers accounted for approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_znqY1bQQKqW2" title="Concentration Risk, Percentage">22</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zaeUQyw1qBH2" title="Concentration Risk, Percentage">19</span>% of total revenues. For the three months ended June 30, 2021, two of the Company’s customers accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zS2vWcE7eP74" title="Concentration Risk, Percentage">24</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zmBfOUH8uyia" title="Concentration Risk, Percentage">10</span>% of total revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the six months ended June 30, 2022, two of the Company’s customers accounted for approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_z7AkKw7QtTvj" title="Concentration Risk, Percentage">17</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zf3NQLNLNE29" title="Concentration Risk, Percentage">14</span>% of total revenues. For the six months ended June 30, 2021, two of the Company’s customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zod1W2o2A4Ua" title="Concentration Risk, Percentage">41</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zt2yHJ7xDSP5" title="Concentration Risk, Percentage">17</span>% of total revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended June 30, 2022, and June 30, 2021, the Company purchased approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CostOfGoodsMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDistributorMember_znz3Zoi7Gild" title="Concentration Risk, Percentage">45</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CostOfGoodsMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDistributorMember_znn1OJYXidd1" title="Concentration Risk, Percentage">51</span>%, respectively, of its products for cost of goods sold from one distributor. For the six months ended June 30, 2022, and June 30, 2021, the Company purchased approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CostOfGoodsMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDistributorMember_zyB0O2r8fhg6" title="Concentration Risk, Percentage">46</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--CostOfGoodsMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDistributorMember_z1kqqGkz01W1" title="Concentration Risk, Percentage">72</span>%, respectively, of its products for cost of goods sold from one distributor.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022, two of the Company's customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zIZoryfoBdrh" title="Concentration Risk, Percentage">36</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zN2aKAtbW6kk" title="Concentration Risk, Percentage">32</span>%, respectively, of its accounts receivables. As of December 31, 2021, two of the Company’s customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zncn82yNuab6" title="Concentration Risk, Percentage">34</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember_zbwPyKLJClTe" title="Concentration Risk, Percentage">30</span>%, respectively, of its accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:ConcentrationRiskDisclosureTextBlock>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" decimals="INF" unitRef="Pure"> 0.22 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember" decimals="INF" unitRef="Pure"> 0.19 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" decimals="INF" unitRef="Pure"> 0.24 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember" decimals="INF" unitRef="Pure"> 0.10 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" decimals="INF" unitRef="Pure"> 0.17 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember" decimals="INF" unitRef="Pure"> 0.14 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" decimals="INF" unitRef="Pure"> 0.41 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember" decimals="INF" unitRef="Pure"> 0.17 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-04-012022-06-30_custom_CostOfGoodsMember_us-gaap_ProductConcentrationRiskMember_custom_OneDistributorMember" decimals="INF" unitRef="Pure"> 0.45 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-04-012021-06-30_custom_CostOfGoodsMember_us-gaap_ProductConcentrationRiskMember_custom_OneDistributorMember" decimals="INF" unitRef="Pure"> 0.51 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_custom_CostOfGoodsMember_us-gaap_ProductConcentrationRiskMember_custom_OneDistributorMember" decimals="INF" unitRef="Pure"> 0.46 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-06-30_custom_CostOfGoodsMember_us-gaap_ProductConcentrationRiskMember_custom_OneDistributorMember" decimals="INF" unitRef="Pure"> 0.72 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" decimals="INF" unitRef="Pure"> 0.36 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-06-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember" decimals="INF" unitRef="Pure"> 0.32 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" decimals="INF" unitRef="Pure"> 0.34 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AnotherCustomerMember" decimals="INF" unitRef="Pure"> 0.30 </us-gaap:ConcentrationRiskPercentage1>
<us-gaap:CommitmentsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_801_eus-gaap--CommitmentsDisclosureTextBlock_z04PlVKCQph3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 11 – <span id="xdx_82B_zKFTph3hpTm1">Commitments</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 1, 2018, the Company entered into an operating lease with an entity owned by a related party calling for monthly payments of $8,641, plus 100% of operating expenses, for a term expiring on August 31, 2019. On September 1, 2019, this lease was amended such that it expired on August 31, 2020, and the rent thereunder was increased to $8,967 per month. On September 1, 2020, this lease was amended such that its term will expire on August 31, 2021, and the rent thereunder was increased to $9,007 per month. On September 1, 2021, the lease was amended such that its term will expire on August 31, 2022, and the rent thereunder was increased to $9,791 per month. Management is currently negotiating a lease extension.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases premises of 6,000 square feet, which it uses as a showroom, in Tulsa, Oklahoma, at a monthly rental of $5,500 for a term that will expire on March 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under an agreement with the supplier of Medtainers entered into in 2018, the Company agreed to purchase a minimum of 30,000 units of product per month. Under the terms of this agreement, the minimum purchase quantity increases by 1% on every anniversary of its effective date and is now 31,218 units per month. The purchase price for units is subject to periodic adjustment for changes in the consumer price index. This agreement will expire on April 30, 2031; however, it can be terminated upon payment of $400,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:CommitmentsDisclosureTextBlock>
<us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zuib8FB3drNe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 12 – <span id="xdx_82D_zK7nFpzQRA0b">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has evaluated all other subsequent events when the consolidated financial statements were issued and determined that none of them requires this disclosure herein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
</us-gaap:SubsequentEventsTextBlock>
<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="#Fact000904" xlink:label="Fact000904" xlink:type="locator"/>
<link:footnote id="Footnote000967" xlink:label="Footnote000967" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">
The Company entered into promissory note conversion agreements in the aggregate amount of $<xhtml:span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_zky6xNofLyOi" title="Debt Instrument, Face Amount">90,000</xhtml:span> and made payments of $<xhtml:span id="xdx_900_eus-gaap--RepaymentsOfConvertibleDebt_c20210101__20210630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable1Member_pp0p0" title="Repayments of Convertible Debt">8,828</xhtml:span> on them as of June 30, 2022. These notes are convertible into shares of the Common Stock at a conversion price of $295 per share. The loans under these agreements are non-interest-bearing and have no stated maturity date; however, the Company is accruing interest at a 10% annual rate.
</link:footnote>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000904" xlink:to="Footnote000967" xlink:type="arc"/>
<link:loc xlink:href="#Fact000906" xlink:label="Fact000906" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000906" xlink:to="Footnote000967" xlink:type="arc"/>
<link:loc xlink:href="#Fact000908" xlink:label="Fact000908" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000908" xlink:to="Footnote000967" xlink:type="arc"/>
<link:loc xlink:href="#Fact000910" xlink:label="Fact000910" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000910" xlink:to="Footnote000967" xlink:type="arc"/>
<link:loc xlink:href="#Fact000912" xlink:label="Fact000912" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000912" xlink:to="Footnote000967" xlink:type="arc"/>
<link:loc xlink:href="#Fact000916" xlink:label="Fact000916" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000916" xlink:to="Footnote000967" xlink:type="arc"/>
<link:loc xlink:href="#Fact000918" xlink:label="Fact000918" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000918" xlink:to="Footnote000967" xlink:type="arc"/>
<link:loc xlink:href="#Fact000928" xlink:label="Fact000928" xlink:type="locator"/>
<link:footnote id="Footnote000972" xlink:label="Footnote000972" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">
On February 22, 2018, the Company made a promissory note in the principal amount of $<xhtml:span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_c20180222__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayable2Member_pp0p0" title="Debt Instrument, Face Amount">298,959</xhtml:span> in favor of an unrelated party, which comprised the unpaid principal amount of $200,000 due on a prior note in favor of that party and $98,959 of accrued interest thereon. The balance of this note was $<xhtml:span id="xdx_905_eus-gaap--NotesPayable_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_zndRrp0cteqa" title="Notes Payable">57,548</xhtml:span> and $<xhtml:span id="xdx_90E_eus-gaap--NotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable1Member_zbFWTJpA9Ic">162,274</xhtml:span> at June 30, 2022, and December 31, 2021, respectively, and accrued interest was $<xhtml:span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayablesMember_zSnHIZgc1pVe">0</xhtml:span> and $<xhtml:span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayablesMember_zT1CT7fGNsO2" title="Interest Payable">889</xhtml:span>, respectively. The Note was due on February 22, 2019. The Company is negotiating an extension.
</link:footnote>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000928" xlink:to="Footnote000972" xlink:type="arc"/>
<link:loc xlink:href="#Fact000930" xlink:label="Fact000930" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000930" xlink:to="Footnote000972" xlink:type="arc"/>
<link:loc xlink:href="#Fact000932" xlink:label="Fact000932" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000932" xlink:to="Footnote000972" xlink:type="arc"/>
<link:loc xlink:href="#Fact000934" xlink:label="Fact000934" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000934" xlink:to="Footnote000972" xlink:type="arc"/>
<link:loc xlink:href="#Fact000936" xlink:label="Fact000936" xlink:type="locator"/>
<link:footnote id="Footnote000981" xlink:label="Footnote000981" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">
On August 15, 2015, the Company made a promissory note in the principal amount of $<xhtml:span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20150815__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Debt Instrument, Face Amount">150,000</xhtml:span> in favor of an unrelated party. The note bears interest at 0.48% per annum, provided that the note was paid on or before its maturity date, or 2 percentage points over the Wall Street Journal Prime Rate, if not so repaid. Upon an event of default, as defined in the note, interest will be compounded daily. This note matured on August 11, 2016. During the year ended December 31, 2017, the holder of this note agreed to exchange $75,000 of principal and $663 of accrued interest on this note for 500,000 shares of common stock. This exchange was accounted for as an extinguishment of debt resulting in a loss of $683,337. In connection with this exchange, the Company agreed to pay the holder a fee of $75,000 in consideration of his waiving the default under the promissory note, as additional consideration for his agreeing to the exchange and as compensation for his foregoing the interest that would have accrued on the promissory note at the default rate but for the waiver. During the six months ended June 30, 2022, and the year ended December 31, 2021, the Company made payments of $<xhtml:span id="xdx_905_eus-gaap--RepaymentsOfNotesPayable_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Repayments of Notes Payable">0</xhtml:span> and $<xhtml:span id="xdx_901_eus-gaap--RepaymentsOfNotesPayable_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Repayments of Notes Payable">11,227</xhtml:span>, respectively, on the principal and $<xhtml:span id="xdx_904_eus-gaap--InterestPaid_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities">0</xhtml:span> and $<xhtml:span id="xdx_900_eus-gaap--InterestPaid_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Paid, Including Capitalized Interest, Operating and Investing Activities">33,775</xhtml:span>, respectively, on the interest accrued on this note. At June 30, 2022, and December 31, 2021, the balance of the note was $<xhtml:span id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_z6UTixnZcbD5" title="Notes Payable">53,020</xhtml:span>, respectively, and accrued interest, including the $<xhtml:span id="xdx_905_eus-gaap--NotesPayable_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableMember_zN3mJdUQe3V8" title="Notes Payable">75,000</xhtml:span> fee included therein, was $<xhtml:span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Payable"><xhtml:span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable2Member_pp0p0" title="Interest Payable">36,980</xhtml:span></xhtml:span>, respectively. The Company is negotiating an extension.
</link:footnote>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000936" xlink:to="Footnote000981" xlink:type="arc"/>
<link:loc xlink:href="#Fact000938" xlink:label="Fact000938" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000938" xlink:to="Footnote000981" xlink:type="arc"/>
<link:loc xlink:href="#Fact000940" xlink:label="Fact000940" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000940" xlink:to="Footnote000981" xlink:type="arc"/>
<link:loc xlink:href="#Fact000942" xlink:label="Fact000942" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000942" xlink:to="Footnote000981" xlink:type="arc"/>
<link:loc xlink:href="#Fact000944" xlink:label="Fact000944" xlink:type="locator"/>
<link:footnote id="Footnote001000" xlink:label="Footnote001000" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">
On June 15, 2020, the Company and a related party entered into a Separation Agreement, dated June 15, 2020, under which, commencing on January 1, 2021, the Company agreed to repay $145,844 that the Company owed him in 24 monthly payments of $6,093, including interest at the Applicable Federal Rate. During the six months ended June 30, 2022, and the year ended December 31, 2021, the Company made payments of $<xhtml:span id="xdx_90A_eus-gaap--RepaymentsOfNotesPayable_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Repayments of Notes Payable">53,513</xhtml:span> and $<xhtml:span id="xdx_906_eus-gaap--RepaymentsOfNotesPayable_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Repayments of Notes Payable">90,000</xhtml:span>, respectively. At June 30, 2022, and December 31, 2021, the balance of the note was $<xhtml:span id="xdx_908_eus-gaap--NotesPayable_c20220630__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Notes Payable">18,681</xhtml:span> and $<xhtml:span id="xdx_90F_eus-gaap--NotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayable3Member_pp0p0" title="Notes Payable">72,193</xhtml:span>, respectively.
</link:footnote>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000944" xlink:to="Footnote001000" xlink:type="arc"/>
<link:loc xlink:href="#Fact000946" xlink:label="Fact000946" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000946" xlink:to="Footnote001000" xlink:type="arc"/>
<link:loc xlink:href="#Fact000948" xlink:label="Fact000948" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000948" xlink:to="Footnote001000" xlink:type="arc"/>
<link:loc xlink:href="#Fact000950" xlink:label="Fact000950" xlink:type="locator"/>
<link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact000950" xlink:to="Footnote001000" xlink:type="arc"/>
</link:footnoteLink>
</xbrl>

↑Top
Filing Submission 0001683168-22-005991   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., May 15, 6:20:12.1am ET